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ABSTRACT
Melvin G. Dodson
Loyola University of Chicago

ISOLATION AND CHARACTERIZATION OF A VULVAR CARCINOMA
IN TISSUE CULTURE:

STUDIES OF THE

TUMOR BIOLOGY AND TUMOR-HOST INTERACTION
LT-2, a squamous cell carcinoma, represents the third
vulvar cancer isolated in tissue culture.
Immunological evaluation of the host revealed markedly
decreased absolute numbers, percentages of peripheral blood
lymphocytes, T-cell, active T-cell, and B-cell.

A response

was noted to only one of five bacterial recall skin test
antigens, which subsequently became negative when re-tested
6 weeks later.

No response was noted to primary immuniza-

tion with DNCB, but the patient became PPD positive following intralesional BCG therapy.
even to PPD within 2 months.

The patient became anergic
No clinical response was noted

to BCG treatment, although a "bone marrow" sparing effect
with an increase in lymphocytes occurred.

No response oc-

curred to immunization with an autologous tumor extract.
Lymphoblast responses to PHA were markedly depressed and no
lymphoblast response occurred to autologous tumor extracts.
ix

cytotoxicity studies using autologous lymphocyte and tumor
cells revealed no specific cytotoxicity and non-specific
cytotoxicity of patient lymphocytes to an unrelated tumor
were depressed.

A significant increase in both specific cy-

totoxicity and non-specific cytotoxicity was noted following
a blood transfusion.
LT-2 has continued to grow in vitro through 70 plus·
subcultivations during a 4 year period.

It grows as a

strict monolayer with no piling up of cells and a plating
efficiency of about 40%.

The doubling time of 34 hours and

the saturation density of 1 x 105 cells/cm2.
serum for growth.

LT-2 requires

In time-lapse cinematography, LT-2 is

motile and small colonies are noted to move together with no
contact inhibition of cell movement (topoinhibition}, although strong lateral cell to cell adhesions were noted.
Cell divisions were also noted in the center of large cell
colonies of LT-2 demonstrating a lack of contact inhibition
of cell division despite monolayer growth.
the

LT-2 produces

-chain of hCG and CEA in tissue culture and was agglu-

tinated by lectins.

It retained its ABH antigens, but ex-

pressed a heterophile antigen and was agglutinated by normal
rabbit serum.

This heterophile antigen was different from

the heterophile antigen expressed in infectious mononucleosus infections.
Karyotyping of LT-2 demonstrated aneuploidy with marker
chromosomes and considerable variation in chromosome numbers.
X

LT-2 was noted to divide in soft agar increasing the
number of cells in agar cultures by about 60%, but no
clones were produced.

Experiments were performed to deter-

mine if a soluble stimulant or inhibition of anchorage independent growth could be detected.

Co-cultivation of an

anchorage independent cervical carcinoma cell line with LT-

2 resulted in stimulation of cell growth with increased
cloning efficiency.
after 2 weeks.

No "feeder effect" was often noted

Mitomycin C treated AU-471 and WI-38 were

also capable of "feeding" AU-471.

The "feeder effect" was

transferable with conditioned media and was generally dose
dependent.
Co-cultivation of LT-2 with mitomycin C or protein extracts of AU-471 did not stimulate anchorage independent
growth of LT-2.
Anchorage independence could not be stimulated by enzyme treatment with carbohydrates, neuraminidase, culturing
in agarose or with DEAE or dibutyrl cyclic GMP.
Fibronectin markedly increased cloning efficiency of
AU-471, but not LT-2 or "normal" cell strains like M.S. or
WI-38, that do not clone in soft agar.

BHK-21 soft agar

cloning was stimulated by fibronectin.

Antifibronectin in-

hibited cloning efficiency of AU-471, but not BHK-21.
jecting LT-2 in nude mice resulted in tumor formation.

InTu-

mor nodules were relatively well differentiated epithelium
with keratin formation toward the center of tumor nodules.
xi

chromosomal analysis of in vitro cultivated nodule cells indicated marked aneuploidy.

Soft agar cultures of LT-2 nude

mouse nodule cells did not produce anchorage independent
growth.

No metastases were noted.

xii
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CHAPTER I
INTRODUCTION
Many approaches have been undertaken in research directed towards uderstanding and treating cancer. Some
studies have investigated one cancer characteristic, or
used one assay in many different cancer types, while others
have intensely studied one protein or one phenotype or characteristic associated with cancer.

This dissertation has

by both necessity and design used a large number of clinical
and experimental assays to

bet~er

appreciate the complex in-

teraction between the tumor and the tumor host.

From an in

depth study of a tumor cell, new insights into the behavior
and characteristics of the cancer cell might be achieved.
The cancer cell model studied was an epithelial carcinoma
originating from the vulva which clinically progressed to
the death of the patient, confirming its biological potential.
Tumor immunology has generated considerable enthusiasm
as a potential method for the treatment of cancer.

Evi-

dence of immune responses to tumor cells have come from a
wide range of clinical and experimental observations in research.

The pariicipation of the immune response in con-

trolling tumors can be discussed under the general concept
1
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of "immune surveillance".

In order to have an immune re-

sponse, tumor cells must contain a "tumor antigen".
host must be "immunocompetent" and
such an antigen.

c~pable

The

of responding to

In order to bring the question of immune

responses from the clinical bedside to the laboratory for
closer scrutiny, in vitro "cytotoxicity" studies have been
developed using host lymphocytes and tumor cells in culture.
Chapter 2, Section A. will summarize pertinent aspects of
these "four topics" under the appropriate headings.
A study of tumor immunobiology cannot divorce itself
from a basic understanding of tumor cell physiology.

Al-

though, on a clinical level, cancer is relatively easy to
define by its biological behavior, the exact criteria of
tumorigenicity on a cellular level in vitro are much more
difficult.

Considerable advancements have been made in

culturing tumor cells in vitro, and a number of cell phenotypes have been found to be associated with tumorigenicity.
A brief review of these cancer phenotypes as pertinent to
this discussion appears in Chapter 2, Section B.
Reported here is the establishment and characterization
of a squamous cell carcinoma of the vulva in tissue culture
(designated LT-2), including evaluation of its malignant
potential, cytomorphology, growth properties, secretory
Products, antigens, in vitro behavior, and immunological

stu~ies of the host, clinical course, therapy, and some asPects of the tumor-host relationship.

3

The following briefly reviews the findings and clinical course of the patient from which the tumor LT-2 was
isolated.
A 60-year-old white woman was seen in June of 1975 with
a two-week history of vulvovaginal itching, swelling, and
discharge.

Extensive induration of the external genitalia

with ulcerative lesions involving the introitus and anterior vaginal wall was noted.
enlarged.

Groin nodes on both sides were

Biopsy revealed squamous cell carcinoma.

Chest

x-ray, intravenous pyelogram (IVP), and liver and bone scans
were normal.

The patient refused surgery and was treated

with radiotherapy consisting of 6,000 rads in 30 fractions
over 56 days through a single perineal port.

Additional

therapy to the inguinal nodes consisted of 4,550 rads in 26
fractions over 36 days.
sions was noted.

Some regression of the vulvar le-

The inguinal nodes remained enlarged and

were treated with an additional 1,050 rads in six fractions.

She did well until December, 1975, when she noted

increasing pelvic discomfort and pain.

By January, 1976,

the inguinal nodes had ruptured through the skin, producing
a fungating lesion.

She was started on dactinomycin, 0.8

mg intravenously, daily for five days and bleomycin, 20
units intravenously every other day for three days.

She

experienced considerable nausea and vomiting and refused
further chemotherapy.

She received two units of blood one

4
month later because of anemia.

Adjuvant immunotherapy con-

sisting of 2 x 106 Bacillus Calmette-Guerin (BCG) organisms
~as

administered intralesionally.

She was started on Cy-

toxan, 50 mg four times daily, depending on the leukocyte
count, and received three additional BCG immunizations during breaks in chemotherapy.

In vivo tests of immunocompe-

tence consisted of skin testing with bacterial recall skiQ
test antigens, dinitrochlorobenzene (DNCB), and autologous
tumor extracts.

In vitro tests of immunocompetence in-

eluded total and per cent peripheral blood T-cells, active
T-cells, B-cells and phytohemagglutinin (PHA) stimulation of
lymphocytes.

The tumor-host

r~lationship

was evaluated by

autologous lymphocyte-tumor cytotoxic reactivity as measured by a chromium release assay, and lymphoblast transformation in the presence of tumor extracts and mitomycin Ctreated tumor cells as described in the text.
died in September, 1976.

The patient

CHAPTER II
REVIEW OF RELATED LITERATURE
TUMOR IMMUNOBIOLOGY
1.

IMMUNE SURVEILLANCE

In a general discussion of delayed hypersensitivity,
Thomas suggested in 1959, that it is a "universal
requirement of multicellular organisms to preserve
uniformity o.f cell type and to prevent mutant cells from
colonizing and flourishing," and that "the phenomenon of
homograft rejection will turn out to represent a primary
mechanism for natural defense against neoplasia'' (1). This
concept was expanded by F.M. Burnet into the concept of
immunological surveillance which suggests that neoplasms
frequently occur and contain new tumor antigens and
subsequently are re~ected by the immune system (2).
According to this concept, it is the immune system that
prevents the host from developing cancer.
Observations that have been used to support the concept
II

of immune surveillance according to Moller et al (3),
include the following:

a) The incidence of neoplasia in

the elderly is increased simultaneously with a decrease in
the efficiency of immune responses.
5

Old mice cannot reject

6
small numbers of sarcoma cells that can be readily rejected
bY younger mice.

Old mice die and young mice are 1mmunized.

b) The incidence of malignancies diagnosed histologically
is much higher than the known clinical incidence; for
example, autopsied infants have 50 times greater
neuroblastomas diagnosed histologically than the known
clinical incidence.

Similarily, the incidence of

histologically malignant thyroid nodules noted in autopsy
specimens is 2%, but the clinical incidence of thyroid
cancer is only 6 per 1x106 individuals.

It has been

suggested that the immune system accounts for these
differences.

c) The increased incidence of tumors in some

genetic immunodeficiency disorders like Ataxia
Telangiectasia (i.e., 14 tumors in 200 reported cases),
Chediak-Higashi (11/50) and Wiskott-Aldrich (11/90) has also
been used to support the concept of immune surveillance.
Gatti (4) has reported that the incidence of malignancy in
patients with primary immunodeficiencies is 10,000 times
that of the general age-matched population.

d) The

increased incidence of tumors in immunosuppressed
individuals, for example in patients receiving kidney
transplants, also confirms the role of the immune systems
in tumors.

In 4,000 renal allograft recipients, 37

developed tumors,· which is estimated to be SOx the expected
incidence.

Israel Penn (5) collected data on 47 kidney

7
transplant recipients who received organs from donors with
cancer; 36% developed cancers histologically identical to
that present in the donor.

Immunosuppressive therapy was

discontinued in 3 patients with known metastasis, and the
tumors regressed and disappeared.

In 432 kidney

recipients, reviewed by Penn, 24 developed neoplasms, an
incidence of 5.6%, which is approximately 100x greater than
the incidence in the general population in the same age
range.

Penn also reported on 48 patients receiving

immunosuppressive therapy for a number of medical problems
like psoriasis, systemic lupus erythematosus, rheumatoid
arthritis and ulcerative colitis, suggesting a possible
increased incidence of cancers in such patients.
The occasional clinical observations of tumor
regression have also been used to support the concept of
immune surveillance.

Everson and Cole reviewed 176

examples of spontaneous tumor regression between 1900 and
1964 (6).

The implication was that the tumor regressed

because of the immune system.
We might add to these observations the occasional
report of dramatic tumor regression using immunotherapy
like BCG and C. Parvum.

In addition to these arguments

supporting the concept of immune surveillance, there have
been extensive animal experimental data implicating the
immune system as an important participant in tumor
Progression.

8

prehn has summarizd the data against immune
surveillance, and feels that the case for immunological
surveillance has been "exaggerated" (7).
Prehn first notes that some "classes of tumors have
many members with little or no detectable immunogenicity".
ThiS lack of tumor antigens would preclude any immunological
surveillance mechanism.

If immunoselection was responsible

for the lack of tumor antigens in spontaneous neoplasia,
then neoplasms arising in immuno-deficient environments
should be highly antigenic.

Prehn tested this hypothesis by

growing tumors in intraperitoneal diffusion chambers, and
found relatively little immunogenicity.

Also mouse embryo

cells, grown in tissue culture and treated with chemical
carcinogens yield tumors showing relatively little
immunogenicity.

Very small inocula of immunogenic tumor

cells sometimes survive and kill the host (a phenomenon
first described by Humphreys et al, and is termed "Sneak
Through" (8), even though large inocula result in effective
immunization and inhibition of tumor growth.

This "sneak

through" phenomenon suggests the immune system is sometimes
ineffective even with immunogenic tumors (9).

"
Moller
and

II

Moller have also pointed out that in several diseases with
pronounced immunosuppression there is no increased tumor
incidence (Leprosy, Sarcoidosis}, and that immunodeficient
patients develop a very restricted range of neoplasms,

9

generallY of lympnoid origin, rather than the common tumors
seen clinically (10).
Further negative data come from animal stud1es.

Nude

mice which lack T-cells and cannot reject foreign grafts,
have a very low spontaneous rate of tumor development.
Rygaard and Povlsen reported on 11,000 nude mice without a
single example of a tumor developing (11).

Simpson and

Nehlsen used antilymphocyte sera to suppress the immune
system in CBA mice and also found no increase in the
incidence of spontaneous tumors (12).

"
"
Moller
and Moller

also point out that immune surveillance should produce a
high incidence of tumors· in immune privileged sites like
the anterior chamber of the eye, cheek pouch of the hamster
and brain.

Yet, these are not common sites of spontaneous

malignancy.
The data implicating the potential for involvement of
the immune system in cancer are impressive, particularly if
the experimental animal data are accepted as a valid
comparison to human cancers.

From a pragmatic point of

view, the question remains one of degree.

How important is

the immune system in the prevention of tumors, not
theoretically but practically?
Experimental systems must be viewed with caution since
many such tumors ·are induced by viruses or strong chemical
ca rc1nogens
·
(mutagens) which have repeatedly been

10

demonstrated to express viral or highly antigenic
mutational antigens.

Therefore, immunological reJection of

such tumors may only reflect the involvement of the 1mmune
system in tissue graft rejection or the killing of virus
infected cells.

Klein and Klein have suggested that immune

surveillance may, in fact, be mainly involved in the
prevention of viral tumors (13).

Prehn's note of caution

regarding tumor antigens would appear to be central to the
controversy (14).
2.

TUMOR ANTIGENS

The first convincing evidence that malignant cells
have antigens not present in the normal precursor cell came
from studies using tumor transplants by Gross (15) in 1943
with syngeneic mice and chemically induced tumors.

Prior to

that time, most reports of tumor antigens were thought to
have resulted from transplantation or histocompatibility
antigens.

Prehn and Main (16) confirmed these findings in

1957 when they showed that skin grafts from tumor donors
were accepted while the tumor itself was rejected,
indicating the presence of antigens on the surface of tumor
cells which are absent on the normal skin of the tumor
donor.

These new antigens, which were responsible for tumor

rejection in the syngeneic host, were originally termed
tumor-specific transplantation antigens, since they were

11
demonstrated by rejection of a grafted tumor.

Results of

further studies by Prehn (17) revealed that two such
chemically induced tumors arising at different sites on the
same mouse had different tumor-specific antigens.

Most

chemically induced tumors have tumor neoantigens.

New

antigens may also arise from spontaneous

mutation~

occurring in any dividing cell population.
Some viruses also induce malignant growth.

The first

virus-induced tumors were demonstrated by Ellermann and
Bang (18) in 1908 and by Rous (19) in 1911.

The presence of

virus-specific tumor rejection antigens was described by
n

Sjogren and associates (20) and independently by Habel (21)
in polyoma virus-induced mouse tumors.
A different type of tumor antigen was demonstrated in

1965 when Gold and Freedman (22) reported an antigen which
was associated with human carcinoma of the colon, and was
also present in fetal tissues.

This antigen, termed

carcinoembryonic antigen, was later found to be associated
with many different types of human tumors and some
non-malignant diseases, as well as normal fetal tissues.
The initial enthusiasm for carcinoembryonic antigen as a
diagnostic test for carcinoma of the colon waned because of
its lack of specificity and its inconsistency of expression
in tumors.

Since these limitations have been appreciated,

carcinoembryonic antigen has becon1e a useful screening tool
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in suspected instances of malignant disease, and is used to
monitor therapy in some patients with cancer (23).
The presence of fetal antigens .in malignant tumors was
n

suggested in 1906 by Schone (24), but the significance of
these antigens was not fully appreciated.

"
Schone
immunized

mice with extracts of fetal tissue and noted resistance to
transplantation of a sarcoma, suggesting the presence of
fetal antigens in the sarcoma.
In addition to recognition of antigens resulting from
chemical or viral transformation or expression of repressed
fetal antigens in tumors, there is now a better
appreciation of the large number of antigens expressed by a
normal cell.

The closer normal cell antigens are observed,

the more complex and varied are the antigenic determinants
noted.

For example, there have been over 379 recognized

normal red cell antigens reported (25).

An increase or

decrease in the number of normal cell antigens may occur
following malignant transformation (26, 27), and some
normal antigens initially have been confused with
tumor-associated antigens (28, 29).
New antigens in tumor cells may also result from
enzymatic change or synthesis.

Such structurally altered

antigens have been noted in studies of both the ABH and MN
blood group system.

13

Not all antigens expressed on a tumor cell can be
explained by a single mechanism of formation.

Any given

transformed cell may express a variety of new antigens,
including those arising from mutation, modulation of normal
cell macromolecules, derepression of fetal genes or
recessive alleles and faulty macromolecular biosynthesis.
3.

IMMUNOCOMPETENCY

Host immunocompetency can be assessed both by in vivo
and in vitro testing.

In vitro methods of evaluation of

immunocompetence in tumor patients include total lymphocyte
counts, T and active T cell subpopulations, lymphocyte
response to mitogen stimulation and specific lymphocyte
response to tumor cells or tumor extracts.

Stefani and

colleagues (30, 31) and Kerman and associates (32), have
shown depression of total T cells, active T cells, and
mitogen stimulation in patients with certain solid tumors.
In vivo host immunocompetence is frequently evaluated
by delayed hypersensitivity skin test responses specifically to tumor antigens prepared from autologous or
allogeneic tumors or nonspecifically through recall
(secondary) responses to microbial skin test antigens and
response to primary sensitization with dinitrochlorobenzene
(DNCB).

It has been found that 90 to 100 per cent of normal

individuals will respond to at least one of a series of
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five ubiquitous microbial skin test antigens and 96.5 per
cent will respond to primary sensitization with DNCB
(33,34,35).

Patients with a wide variety of tumors have

shown depressed responses to both recall antigens and
primary immunization.

Nalick and co-workers demonstrated

depressed responses by both parameters in cervical,
uterine, ovarian, and vulvar cancers (36).

Eilber and

Morton reported a correlation of DNCB responsiveness to
prognosis (37).

Ninety-six per cent (50 of 52) of patients

who were DNCB non-reactive were either inoperable or
developed recurrent cancer within 6 months.
In some tumors,

imm~nocompetence

may correlate with

prolonged survival and/or stage of disease (38).

However,

reports vary considerably as to the prognostic value and
dependability of different immune parameters.

Even when a

correlation exists for a tumor of a given histologic type
between immunocompetence evaluations and state of disease
or prognosis, it cannot be easily extrapolated to other
types of tumors.

In addition, even in studies showing

statistical correlation between immunocompetence and
prolonged survival, any individual patient may show good
immune response in the face of tumor progression,
deteriorating clinical condition, and death or poor immune
response and prolonged survival.

Eilber and Morton noted

two patients who were DNCB positive despite widespread
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metastasis and they remained positive until their death
( 39).
Attempts have been made to use immune stimulation for
tumor therapy.

Bacillus Calmette-Guerin (BCG) has been

used extensively as the primary mode of immunotherapy.
Generally, limited success has been noted, although
occasional good responses have been reported in individual
cases.

The rationale for BCG immunotherapy includes

stimulation of cellular immunity, possibly resulting in
enhanced sensitization and consequent immune response to
tumor antigens leading to tumor regression.

A bone marrow

- sparing effect has been reported with BCG, increasing the
number of peripheral blood lymphocytes giving the potential
for delivery of increased doses of chemotherapeutic agents
that produce leukopenia (40).
Of even more interest is the response of cancer
patients to extracts of their own tumor.

Herberman (41)

noted that skin tests for delayed hypersensitivity to tumor
extracts have two principal objectives:

a) a means of

detecting antigens on tumor cells, and b) as a mechanism for
assaying host cellular mediated immune responses to
neoplastic disease, and correlation of such responses to
resistance to tumor g~owth, clini~al status, prognosis, and
for monitoring patients during therapy.
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Delayed-type hypersensitivity reactions (DTH) have
been reported in 72% of patients to extracts of leuKemias
and lymphomas (42).

Fass noted positive DTH in 61% (8/13)

of patients with Burkitt's Lymphoma, and noted a correlation
with clinical status (43}.

Stewart found specific DTH

responses to autologous tumor extracts in 26% of a group of
134 patients with lung cancer (44}.

Fass, et al, also

reported positive skin reactivity to autologous tumor
extracts in 3 patients with malignant melanoma with
localized disease, and an absence of reactivity in 5
patients with advanced disease (45}.
Herberman suggested· that in vivo skin testing to
autologous tumor extracts had several advantages over in
vitro testing of host cellular mediated immunity:

its

simplicity, elimination of the need for tissue cultures,
availability of better controls using normal tissues which
are more difficult to grow in vitro, and a better reflection
of results of in vivo skin testing with the immune status
of the patient.

The disadvantages of in vivo skin testing

are the difficulty of precise quantitation, the necessity of
patient cooperation, and the fact that such testing involves
the use of tumor tissue (extracts} in human subjects.
Care must be used in interpretation of autologous tumor
DTH, since skin t·est reactivity to extracts of normal
tissue has been reported.

Bacterial contamination may also

be responsible for false positive skin test (46,47).
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4.

CYTOTOXICITY

Cytotoxicity may result from a wide variety of
biological, physical and chemical agents.

Three general

"types" of immunological cytotoxicity are recognized:

a)

complement mediated antibody dependent cytotoxicity (CMAD),
b) antibody dependent cell mediated cytotoxicity (ADCC),
and c) cell mediated cytotoxicity (CMC).
a.

COMPLEMENT MEDIATED ANTIBODY DEPENDENT
CYTOTOXICITY (CMAD)

Kalfayan and Kidd (48) in 1953 noted tumor cell
swelling in the presence of antibody and complement, and
Gorer and O'Gorman (49) noted tumor cell killing in vitro in
1957 as judged by vital dye exclusion (trypan blue) after
incubation with isoantibodies and complement.

Green, et al

reported cellular leakage of radioactive molecules from
ascites cells in the presence of antibody and complement,
and suggested that
membrane (50).

~omplement

induced "holes" in the cell

These "holes" when visualized by electron

microscopy, are uniform, stable structures 100 A0 in
diameter; and result from insertion of complement
components into the cell membrane, forming a doughnut-like
hole (51).

Although IgM, IgG1, IgG2 and IgG3 antibodies

can "fix" complement with resulting cytolysis, IgM is 800
times more effective than IgG (52).
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Despite the undeniable fact that antibody and
complement can result in cytotoxicity, the role of such
humoral immunity to tumors remains quite controversial.
Tumor cells very considerably in their susceptibility to
cell lysis by CMAD (53), and evidence has even been
presented suggesting that antibodies might "protect" tumors
from cell-mediated cytotoxicity resulting in tumor
enhancement (54).
The existence of antibodies to tumor-associated
antigens has variably been reported, but in the opinion of
Herberman, not adequately proven (55).

Multiple reports

have probably adequately confirmed the existence of
anti-tumor antibodies in patients with at least three
different types of tumors:

1) Burkitt's Lymphoma, 2)

malignant melanoma, and 3) sarcomas.

Theofilopoulos in

1977 reported immune complexes in about half of patients
with melanoma, colon carcinoma, and osteogenic sarcomas
(56).

Hoffken et il 1978, noted circulating immune

complexes in the initial stages of chemically induced
carcinomas (3-methylcholanthrene) that returned to normal
with tumor excision and also decreased in concentration with
continued tumor progression (57).

Antibody responses also

occurred in viral induced tumors (Mammary Tumor Virus in
BALB/cfC3H female mice), with specificities against not
only viral antigens, but also against a wide variety of
unique specificities (58).
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Hellstrom reported an' enhancement of tumor growth by
hyper-immune serum (59).

This effect was initially thought

to result from blocking antibodies (60).

The effect of

serum in tumor growth enhancement was found to be specific.
others have also reported tumor cell enhancement (61,62).
The tumor growth enhancement could be removed by absorption
with specific tumors (Moloney sarcoma), but not with control
cells (63).

The serum effect was initially thought to be

due to antibodies that "blocked" cell-mediated
cytotoxicities (CMC).

Such CMC blocking was confirmed by

"
Sjogren
et al (64) and by Baldwin (65}.

The concept of

"blocking antibodies" was based on the observation that:

1)

blocking activity could be removed by absorption with
specific tumor cells, and 2) blocking occurred if target
cells were incubated with serum, but not if lymphocytes
were incubated with serum.

The concept of "blocking

antibodies" had to be modified when the blocking effect was
noted to disappear shortly after tumor regression or
surgical removal of tumors.

Sera from such tumor-free

animals was found to be "unblocking" and the blocking
activity was then felt to result from antibody-antigen
complexes, and unblocking from antibodies (66).

The

blocking effect is reported to occur at either the target
cell or effector cell level by antigen-antibody complexes.
Free antigen blocked at the effector cell level.

These
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observations were partially substantiated by Baldwin using
papain solubilized tumor antigens (67).

Neither antigens

nor antibodies to the same antigens blocked CMC, but
complexes in the right proportion were capable of blocking
at the level of the target cell, and both complexes and
free antigens were found to be capable of blocking at the
level of the effector cell.

CMC reactivity using patient

lymphocytes against histologically similar tumor cells was
also used as evidence of histological type specific
reactivity, and suggested similar antigens in patients with
histologically similar type tumors (68).
The importance of the observation in vitro is suggested
by the correlation between blocking factors against CMC and
melanoma growth.

Hellstrom noted a correlation between

blocking factors against CMC and melanoma growth (69).
It

Bansal and Sjorgen confirmed these findings in vivo using a
polyoma viral induced tumor in rats (70).

Murray reported

a 15,000 dalton blocking factor that bound both to Con A
and to melanoma antibodies, and which was also found in the
supernatants and membranes of melanoma cells in tissue
culture ( 71 ) .
How these observations integrate with more recent
observations regarding ADCC is not clear.

The lack of

normal reactivity (spontaneous cell mediated immunity, SCMC
or natural cytotoxicity) in these studies is very
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questionable (72).

The histologic type-specific reactivity

haS also been seriously questioned (73).

Takasugi, Mickey

and Terasaki reported on cytotoxicity reactions involving
peripheral blood lymphocytes in a variety of cancer patients
using 45 different human tumor cell lines with 9294
different lymphocyte-tumor combinations and found no
correlation between CMC and "histologic types" of cancers
(74).
b.

ANTIBODY DEPENDENT CELL MEDIATED CYTOTOXICITY
(ADCC)

Like CMAD, ADCC requires antibody; however, in ADCC,
lysis results from the interaction of an effector cell with
antibody coated target cells rather than complement.
Therefore, ADCC is complement independent.

ADCC has been

thought to be exclusively a function of IgG (all
subclasses), although one report has indicated that IgM may
also be capable of initiating ADCC (75).

Effector cells

bind to the Fe portion of the antibody, and do not have to
be previously sensitized.
in the antibody.
required.

The specificity of ADCC resides

Effector-target cell interaction is

Effector cells must be viable in order to

participate in ADCC, although DNA synthesis is not required.
A wide variety of cells has been capable of participating as
effector cells in ADCC including polymorphs, macrophages,
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mononuclear cells, K cells, and even fetal liver cells
( 7 6) •

c.

CELL-MEDIATED CYTOTOXICITY

Kidd and Toolan in 1950 noted that tumors or tumor
cells mixed with lymph node cells when inJected into
recipient animals resulted in tumor growth and eventually
host death, but tumor cells mixed with specifically
sensitized lymphocytes resulted in tumor prevention or at
least retardation of tumor growth (77).

In 1955, using

allografts, Mitchison noted that in vitro cells could
mediate cytotoxicity (78).

Graft rejection could be

adoptively transferred with lymphocytes, but not with
serum.

Winn in 1960, noted reduction of allogeneic tumors

when specifically sensitized lymphocytes were injected along
with the tumor cells (79).

Govaerts reported in vitro

cytotoxicity using dog cell monolayers following in vitro
incubation with specifically sensitized lymphocytes (80).
Following these early observations, a large number of
experiments has been performed to evaluate in vitro
cell-mediated cytotoxicity against tumors.
In vitro CMC studies involve the use of an effector
cell responsible for the cytotoxic action, a target cell,
and a mechanism of measuring the cytotoxic effect.
variety of effector cells has been used in the past

A wide
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including monocytes, macrophages, polymorphonuclear
leukocytes and lymphoid cells from lymph nodes, spleen,
thymus or peripheral blood.

Likewise, a wide variety of

normal and tumorigenic target cells has been used.
Frequently, allogeneic tumor cells of the same histological
type as the lymphocyte donor have been used in assessing
tumor patient cytotoxicity.

Occasionally syngeneic or

autochthonous tumor lymphocyte combinations have been used.
More recently, cytotoxic effects of non-immunized
mononuclear cells against normal and even self tissue have
been recognized (81).

A wide range of techniques has been

used to measure and quantitate the effector-target
cytotoxic interaction including:

early experimental

observations of cytopathic changes in monolayer plaques;
exclusion of supravital dyes by target cells; cell counting;
colony inhibition or colony formation in soft agar; release
of radiolabeled proteins, amino acids, 32p or 51chromium
(82).

The effector target interaction may occur in

allogeneic or autologous serum, and length and condition of
incubation vary as well as manipulations in the processing
of effector and target cells.
The mechanism of cytotoxicity is not known, although
Ferluga et al reported cytotoxicity resulting from plasma
membranes of peripheral blood lymphocytes (83).
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CMC is antibody and complement independent and may be
specific (directed against target cells expressing specific
antigens) or non-specific (resulting from release of
cytotoxic soluble substances or from the action of
nonsensitized but activated effector cells).

As noted

above, a variety of effector cells can produce cytotoxic
reactions including macrophages, T-lymphocytes,
a-lymphocytes, and natural killer (NK) cells.
Two general types of macrophage cytotoxicity have been
described.

One type, resulting from "Activated" macrophages

is not immunplogically specific, the other is
immunologically specific, and is a function of "armed"
macrophages.
Armed macrophages demonstrate immunological
specificity.

The mechanism of "arming" is not known.

Armed

macrophages may be generated in vitro or in vivo by exposure
of immunized lymphoid cells to antigen.

Evans reported a

specific T-cell proauct (specific macrophage arming factor
(SMAF) that armed macrophages (84).

The possibility of

cytophilic antibodies has also been suggested as "the arming
agent", since treatment of macrophages with trypsin or heat
inactivation of serum at 56oc for 30 minutes results in loss
of specific cytotoxicity which could be restored by immune
serum.

Armed macrophages (specific reactivity to a

Particular antigen like SRBC) can be activated (with non-
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immune inhibition of tumor cell growth) by exposure to
specific antigen (SRBC) (85).
Macrophages may be activated by factors from T cells
or by substances like endotoxin, peptone, starch, glycogen,

acG,

double-stranded RNA, or exposure to intracellular

pathogens like toxoplasma (86).

Activated macrophages may

also be obtained by exposing "armed" macrophages to specific
antigens.

The cytotoxic action is non-specific, but

reportedly only abnormally growing cells are killed (87).
The recognition mechanism is nonimmune and not based on H-2
foreign target cell antigens.

Instead, the cytotoxic

action is based on recognition of cell properties associated
with abnormal growth characteristics.

Contact-inhibited

nontumor 3T3 fibroblasts are spared, but transformed
(SV-40) 3T3 fibroblasts which have lost contact inhibition
are killed (88).
The mechanism which macrophages use to distinguish
cancer from a normal cell is not known. Inhibitors of
protein synthesis (puromycin, cycloheximide), DNA synthesis
(mitomycin C, actinomycin D) or inhibitors of phagocytosis
(cytochalasin B) have no effect on the cytotoxic
capabilities of activated macrophages.

The mechanism of

killing is thought to result from."secretion" of lysosomal
enzymes into the target cells (89), because it is inhibited

by hydrocortisone (which also inhibits lysosomal
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exocytosis), and trypan blue (inhibits lysosomal enzyme action).

No cytotoxic factor(s)

is/are noted in cultured me-

dia of activated macrophages suggesting that cell-cell contact is needed for the cytotoxic effect (90).
d.

SPONTANEOUS CELL MEDIA·rED CYTOTOXICI'rY ( SC_MC)

More recently, cytotoxicity of non-sensitized effector
cells has been recognized and termed spontaneous or natural
cytotoxicity.

The effector cells have been called the nat-

ural killer or NK cell.

Early reports suggested a non-T,

Fe+, C3+ cell as the responsible effector cell (91).

The NK

cell has been characteri~ied by Eremin as aT-neg. (nonthymus cell), Fe+, C3-, Ig+ cell in peripheral blood (92),
similar or identical to the K cell of ADCC (a B-cell, but
not requiring antibody for cytotoxic effect).

In contrast,

the NK cell in tonsils and lymphnodes was found to be an
Ig-, Fe-, c3-, T+ cell.

Vessella reported data suggesting

that cells mediating SCMC were a heterogenous population
composed of Fe+ lymphocytes both with and without C3 rec2ptors (93).

Vessella also suggested that the cells responsi-

ble for ADCC and SCMC are identical although the mechanisms
are different.

Hersey has suggested that an "activated" T-

cell is responsible for SCMC (94).

Removal of the Fe bear-

ing cell decreased responsiveness, although depletion of
phagocytic cells did not affect SCMC activity.

Oehler noted
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an increase 1n NK cytotoxicity following intraperitoneal
injection of

~~~~Y-~~,

Poly I:C (Polyinosinic-Polycytidylic

Acid), LCMV (lymphocytic choriomeningitis virus) and KRV
(Kilharn rat virus)

(95).

Treatment with hydrocortisone, X-

irradiatioil or cyclophosphamide suppresseJ SCMC in vivo,
but Poly I:C following such treatment restored cytotoxicity.

Silica also reduced SCMC which could not subsequently

be restored with Poly I:C.
SCMC.

Thymectomy had no effect on

Oehler used these observations to suggest that pha-

gocytosis plays a role in SCMC, although T-cells do not, and
implicates interferon as possibly playing an important role
in SCMC (96).

Menon et al have demonstrated a decrease in

SCMC in tumor patients, and noted a correlation between PHA
responsiveness and SCMC (97).
lator of T-cells.

PHA is a non-specific stimu-
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a.

TUMOR CELL PHYSIOLOGY
1.

TISSUE CULTURE

HeLa was the first human carcinoma cell line to be
established in vitro.

It was isolated by Gey (98) from a

squamous cell carcinoma of the cervix in 1951, and since
then has been maintained in continuous culture.
Established gynecolojic tumor cell lines include carcinomas
of the cervix, ovary, uterine endometrium and chorion.

No

exact record of the number of gynecologic tumor cell lines
is available.

Fogh and Trempe {99), Gall (100), Pattillo

(101), Nelson-Rees (102)., DiSaia {103), and the American
Type Culture Collection {104), collectively have listed 15
cervical, 13 ovarian, and three uterine tumor cell lines,
but not all of these have been characterized.
lines may also now exist.

Other such

The in vitro cultivation of

vulvar carcinoma cell lines has been reported by Giard and
associates (105), in 1973 and Fogh and co-workers (106} in
1977.
Ironically, the proliferation of established human
carcinoma cell lines may not be as abundant as previously
believed, since many cell lines have been found to be
contaminated with HeLa or even animal cells (107,108).
Other cell lines ·used in various studies have not been
well-characterized, and even the origin of some lines is
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vague.

When a tumor is cu1tured in vitro, it is important

to determine that the cells that establish themselves are
in tact malignant.

The capability of continual

subcultivation in vitro, abnormal karyotype, growth in soft
agar suspension, ana the ability to grow and form tumors in
immuno-suppressed or immunodeficient animals are frequently
used criteria of malignancy (109-114).
A number of continuous malignant cell lines have been
used in studies involving the biochemical, biological,
genetic, and ultra-structural properties of cancer cells.
In addition to studies of tumor cells per se, cultured cells
have been used to evaluate the host's immune response
(immunocompetence) to the tumor.
2.

CONTACT INHIBITION: SATURATION DENSITY

The behavior of cancer cells and normal cells has been
compared in tissue culture and correlated with the in vitro
potential for tumor' growth.

Normal cells grow in strict

monolayers, but cancer cells pile up often forming multiple
layers.

Abercrombie and Heaysman initially explained the

tendency of fibroblasts to remain as monolayers on the
substratum as contact inhibition (115).

Middleton notes

that although monolayering is commonly used to designate
contact inhibition, there are other potential explanations
for monolayer growth (116).

Steinberg has emphasized the
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point that con tact ini1 ib it ion can be used to designate
several phenomena:

contact inhibition of cell movement

implying cessation of cell movement secondary to cell-cell
contact; contact inhibition of growth implying inhibition
of cell growth and division with cell-cell contact.

The

term may indicate the behavior of one cell when it collides
with another cell in which there is a cessation of
locomotion in the direction that brought about the
collision; or the term may even be applied to the behavior
of whole populations of cells and imply monolayer growth
(117).

Monolayer growth resulting from contact inhibition

can readily be appreciated in vitro on inspection of
confluent cell cultures.

The phenomenon can be quantitated

by measuring the cell density of confluent cell cultures
and is termed saturation density.

Pollack et al, reported

a correlation between contact inhibition by saturation
density, and in vitro tumorigenicity (118).
Although the mechanism of

conta~t

inhibition is not

known, Abercrombie (119) has suggested that it might result
from:

the inability of the dorsal surface of one cell to

provide a substratum for locomotion for another cell, or
the development upon cell-cell contact of strong lateral
adhesions such that further movement in the direction of
the adhesions is impossible.

studies by Middelton

demonstrated that epithelial cells, layered over a
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confluent monolayer of the same cell type failed to spread,
suggesting that the dorsal surface of the normal cell does
not provide an adequate substratum for attachment and
locomotion for another cell of the same type (120).
Also, Steinberg has noted cell movement in time-lapse
studies from confluent 1nonolayer cultures with cells in
mutual contact on all sides (121).

Steinberg concluded that

the avoidance of overlapping rather than the inhibition of
locrnnotion was responsible for monolayer growth.

3.

SERUM DEPENDENCE

Almost all normal cells require serum for growth in
vitro.

Tumors have been noted to have a reduced

requirement for serum factors (122).

This has been

demonstrated by Holley using SV-40 transfocmed 3T3 cells
(123).

Holley noted that the active material in the serum

is a 100,000 dalton, non-dialyzable factor which is
destroyed by pronase treatment.

Smith and Temin have

suggested that tumor cells might adopt a serum free culture
condition by producing their own growth factor (124).

The

growth factor in serum must be produced by some cells within
the body, and since cells of the same origin all have the
same genetic material, this would be conceivable.
Temin, have in fact,

Smith and

isolated such a growth promoting

factor from conditioned media from a cell line that is serum
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independent.

Gospodarowicz et al have reviewed the mitogen

and growth factors found in serum and plasma, and note that
tnere is a complex mixture of substances including epidermal
growth factor (EGF), fibroblast 3rowth factor (FGF), nerve
growth factor (NGF), insulin, nonsuppressible insulin-like
activity (NSILA), colony-stimulating factor (CSF),
somatomedins (125).

More recently, Guinivan et al, using

normal rat kidney (NRK) and Kirsten sarcoma virus
transformed NRK cells (Ki-NRK) reported that cells were
stimulated by EGF ann expressed high concentrations of EGF
receptors.

Ki-NRK cells were unresponsive to EGF and no

receptors were detected •.

Cross feeding experiments

demonstrated the production of a heat-stable substance from
Ki-NRK cells that stimulated DNA synthesis in NRK cells,
independently of the presence of serum or epidermal EGF
(126).
Despite the good correlation of in vitro serum
independence of cells with in vivo tumor formation, Shin
has noted that serum independence can be disassociated from
in vivo tumorigenicity (127).
Interestin~ly 1

Stanbridge et al (128) were able to

disassociate anchorage independent and nude mouse growth as
separate genetic phenotypes using HeLa and normal
fibroblast fusion hybrids.

Their findings suggest that the

properties of serum independence, anchorage independence,
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loss of contact inhibition (density dependent limitation of
growth) and lectin agglutination do not by themselves or in
concert endow a cell with tumorigenic potential.
stanbridge suggested that the in vitro transformation
phenotypes are dominant traits whereas malignant behavior
in vivo is a recessive trait.
4.

LOCOMOTION

Both normal cells and tumor cells have been reported
to show locomotion in tissue culture.

In normal cells,

contact inhibition is important in controlling cell
movement in vitro (129).·

Collisions between cells lead to

the development of stable adhesions (130).
cells show motility in vitro.

Not all tumor

Hosaka et al, studied the

motility of four strains of rat ascites tumor cells and
noted no locomotion in two of these strains (131).

Tickle

et al, tried to correlate cell movement and invasiveness
using a variety of tumor cells implanted into developing
chicken wing buds.

The results suggest that cell movement

may not be a common factor in all invasive tumors (132).
Trophoblasts, sarcoma 180, and cultured hamster fibroblasts
did invade the mesenchyme, but appeared to do so by
different mechanisms.
tissue.

Trophoblasts dest~oyed adjacent host

Even cells that showed contact inhibition were

capable of movement and tissue invasion.
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5.

KARYOTYPE ·

Aneuploidy is a common finding in cancer cells; it has
almost become an integral part of any definition of cancer a cellular criterion of malignancy.

Boveri in 1941 noted

that malignant cells are cells with genetically unbalanced
chromosomal complements (133).

Boveri's intuition

regarding chromosomes and cancer was confirmed in 1952 by
Makino (134).

Atkin has reviewed the subject, and has

noted that data fail to disclose any simple chromosomal
change common to all cancers, and that considerable
variations occur in different cancers (135).
Spriggs has posed a particularly pertinent question:

Do chromosomal changes occur before or after malignant
changes? (136).

If chromosomal changes are seldom or

inconsistently present in precancerous stages of tumors,
then they can be dismissed as inessential features, but if
chromosomal changes are regularly found in lesions
preceding cancer bi many years, then these changes may play
an integral part in the carcinogenic process.

Not enough

precancerous lesions have been studied to confidently
answer this question to date, but Spriggs' review of
cervical dysplasia and carcinoma in situ would suggest that
many of these lesions do in fact have abnormalities in
chromosomal numbers and/or abnormal marker chromosomes long
before invasion and metastasis occur.

Indeed, this
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supports the suggestion that aneuploidy does play a central
role in the development of cancer.
Most carcinogens, includin0 viral, chemical or
radiation are known to produce chromosomal breaks, and a
number of inherited disorders known to be associated with
cnromosomal breaks like Bloom's Syndrome and Fanconi's
Anemia are also associated with an increased incidence of
cancer { 137}.
Katayama and Woodruff have noted aneuploidy in both
carcinoma in situ and invasive carcinoma of the vulva
{ 1 38 } •

6.

HISTOLOGY

~torpholog

ical changes in cells have in the past been

the most widely used criteria of malignancy, and have
served clinical medicine well as a means of distinguishing
normal tissue from its malignant counterparts.

Despite the

developments in oncogenic pathology and cytology, exceptions
do occur, as well recognized in the difficulty in
distinguishing between benign and malignant thyroid tissue.
The criteria and morphological hallmarks of malignancy
sometimes vary in different tissue types.

Morpnological

criteria for spontaneous chemically induced tumors have
also been studied in experimental animal systems.
Morphological changes which have been reported to correlate
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with neoplastic transformation include:

pleomorphism in

cell and/or nuclear size and shape; increased
nuclear-cytoplasmic ratio; prominent enlarged or numerous
nucleoli; basophilic cytoplasm; abnormal mitosis; reduced
intercellular cohesiveness with piling up of cells; and
reduced cytoplasmic spreading.

The cytoplasmic criterion

which Montesano et al noted to correlate best with
tumorigenicity was increased nuclear cytoplasmic ratio, and
basophilic cytoplasm (139).

Cytodiagnosis was reliable in

94% of 18 cultured rat liver tumor cell lines.
Electron microscopic studies of multiple tumor systems
have not shown any specific or universal patterns in
cancers (140).

Mao, Nalcao and Angrist studying grade 1

adenocarcinomas could not distinguish malignant from normal
or hyperplastic tissues (141).

Ultra structure differences

are generally quantitative rather than qualitative.
7.

ANCHORAGE INDEPENDENT GROWrH

The physiological and biochemical alterations which
result in anchorage independent growth of tumor cells are
not known.

Tucker et al, noted that decreased cytoplasmic

spreading resulted in increased growth in suspension, and
also noted variation in cloning efficiency from cell line
to cell line by a 200 fold range (142).

Variations in

cloning efficiency at different inoculum sizes were also
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noted.

A decrease from 105 to 104 cells in soft agar

resulted in an increase in cloning efficiency of from 6 to
1000 fold ..

Kimball et al, also reported that increasing

concentrations

tlf

cells decreased soft agar cloning

efficiency (143).

Mavligit et al, reported that a large

percentage of non-viable cells could inhibit in vitro growth
in soft agar (144).

MacPherson and Bryden noted an

increase in cloning efficiency if responder cells were
co-cultured in soft agar with x-ray or UV-radiated or
mitomycin C treated "feeder" cells (145).

A 4 fold

increase in cloning efficiency was noted in the range of .5
- 1.0 x 105 feeder cells, but a 38% reduction in cloning
when feeder cells were reduced to .1 x 105 cells.

No

feeder effect was noted when as few as 0.05 x 105 feeder
cells were used.

Dextran sulfate and heparin have been

reported to decrease soft agar cloning reportedly because of
their strong negative charges.

Conditioned media, collagen,

increased serum, insulin, DEAE-dextr~n and a variety of
viruses have all been reported to increase soft agar growth
(146).

Cells grown in agar which form colonies may be

subcultured on conventional culture plates by removing
colonies from the agar with finely drawn pipettes producing
a colony of cells derived from a single cell.

Such cells

when grown as monolayer cultures in vitro and replated in
soft agar show a high plating efficiency between 40% and
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Even cells that do not form

70%.

coloni~~s

re1na in viable in

soft agar suspension as manifest by their ability to absorb
neutral red after 10 days (147).

Salmon and Buick have

described a methodology for fixing colonies in soft agars
and drying them onto microscopic slides for permanent
preservation and staining (148).
Normal cells do not multiply in liquid or semi-solid
suspension cultures.

Cancer cells and some cell lines

derived from normal tissue but carried through many
generations will grow in suspension.

Also, some virus

"transformed" cells will grow in semi-solid suspensions
(149).

MacPherson, in 1964, first used this property of

growth in suspension as an in vitro test of malignancy by
culturing cells in soft agar (150).

Since that time, many

investigators have reported a good correlation between
biological potential of malignancy as manifested by growth
and tumor formation in an appropriate animal host and
anchorage independent gcowth and colony formation in soft
agar.

Colburn et al, studied transformation in BALB/C mouse

epidermal cells following treatment with chemical
carcinogens, and reported a strong correlation between
anchorage independent growth and tumor formation in
syngeneic mice (151).

Montesano et al compared cytology,

production of plasminogen activator and soft agar growth of
22 tumors and non-tumorigenic rat liver epithelial cultures
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(152).

There was

a poor correlation of tumorigenicity with

plasminogen activator production, but a good correlation
with anchorage independent growth, although Marshall et al,
reported two tumors derived from human bladder carcinoma
that were nontumorigenic in nude mice, but which grew in
soft agar, and one cell line that grew in the nude mouse,
but would not clone in soft agar (153).

Dexter et al,

reported a complete loss of soft agar growth when cells were
plated in the presence of polar solvents
(N,N-Dimethyl-formamide) (154).

No tumors were produced in

nude mice inoculated with treated cells.

Removal of polar

solvents from the culture media resulted in appearance of
anchorage independent growth.

Courtenay et al attempted to

culture 40 fresh human tumors from a variety of tissues in
soft agar.

Colonies were noted in 22 soft agar cultures

with a plating efficiency varying from 0.02 to 15% (155).
More recently, Salmon et al has used soft agar growth as a
mechanism of quantitation of differential sensitivity of
human tumor cells to anticancer drugs (156).
8.

FIBRONECTIN

In 1948 Morrison et al isolated a cold-insoluble
globulin (CIG) from h·uman plasma .. Since that time, CIG has
been noted to have a wide variety of blological activities,
and it has acquired a considerable number of synonyms
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including cell surface protein, large external
transformation sensitive protein (LETS), and fibronectin,
which is derived fr-om the Latin "fibra" meaning
tie, and which characterizes its biofunctional

tn

l)ind or

properti~s

{157).
?ibronectin is a major cell sur-face glycoprotein with a
molecular weight of 220,000 daltons (158), and exists as?
dimer cross-linked by a disulfide bridge.

It constitutes

about 3% of the total cell protein (159).

The plasma and

cell forms differ slightly.

Fibronectin is found in the

human plasma at a concentration of 0.3 mg/ml.
The carbohydrate portion of the molecule consists of
4-6 oligo-saccharides with terminal galactose, sialic acid
and fucose linked by N-glycosidic bonds to asparagine.

It

is not necessary for synthesis, processing or secretion, but
appears to protect the molecule from rapid degradation.

The

half life of fibronectin is 36 hours, and cell
concentration is highest in the G phase of the cell cycle,
and lowest during mitosis.

The diffusion constant for

fibronectin is 5x1s-12 cm2/sec., indicating a relatively
immobile molecule on the cell surface (160).
Fibronectin is an integral part of adhesion plaques
forming an interface between the cell and the substratum
(161), and its secretion by the cell is both time and

temperature dependent.
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Fibronectin is responsible for cell-cell and
cell-substrate interaction, for maintenance of normal cell
morphology (162).

It will also agglutinate sheep

erythrocytes in vitro.

Agglutinating activity is destroyed

by proteases, chelating agents or boiling.

Tumorigenicity

of cells transplanted into nude mice also correlates witn
decreased fibronectin (163).
There is a decrease in m-RNA for fibronectin, and
therefore a decreased biosynthesis in transformed cells,
although Yamada and Olden reported no decrease in
fibronectin .in 12 of 89 transformed cell lines (164).
Transformed cell lines and permanent (immortal) cell lines
required plasma fibronectin for substratum adhesion, but
cell strains attacheJ and spread in the absence of
exogenous fibronectin (165).

Addition of fibronectin

restores cell spreading and normal morphology to
transformed cells.

This restoration of more normal

cellular behavior and morphology is prevented by the
presence of anti-fibronectin (166).
9.

IN VIVO GROWTH IN THE NUDE MOUSE

In addition to the progress made in in vitro
propagation of human tumors, progress has also been made in
the in vivo establishment and propagation of such tumors.
Several in vivo methodologies have been explored, including
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the use of thymectomized and cadiated mice oc the tceatment
of cecipient animals with antilymphocyte secum.

A

particularly useful mechanism was described in 1969 by
Rygaard and Povlsen using a congenitally athymic mutant
"nude" mouse {167).

Since their original description,

numerous reports have appeared using the nude mouse as a
mechanism for establishing or serially passing human or
animal tumors.

Shimosato et al, histologically confirmed

an initial transplant "take" in 22 of 91 human tumors, and
successfully serially transplanted 14 {168).

Fogh et al

reported growth of 127 cultured.human tumors in the nude
mouse (169).

Stiles noted that every tumor cell line that

was tumorigenic in some other animal host or of neoplastic
origin was also tumorigenic in the nude mouse.

Some human

tumors that have been particularly difficult to establish in
tissue culture have been established in the nude mouse
(170).

Bastert reported growth in the nude mouse of 85% of

44 human breast cancers (171 ).
Morphology of the original tumor is generally
maintained, {172), although scirrhous tumors such as
stomach and breast tend to become medullary with a deccease
in the amount of tumor stroma.

Some tumocs may exhibit a

higher degree of differentiation Jn the nude mouse than in
the original tumor {173).

Production of tumor products such

as mucin in gastric carcinomas or melanin in malignant
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melanomas as well as ectopic hormone production
(adcenocorticotropin)
tcansplants (174).

is maintaine<l in the nude mouse

Tumor

also 1naintained (175).

anti~enicity

and karyotype are

Altnough normal tissue (skin, etc.)

can readily be transplanted onto the nude mouse, normal
cells or grafts do not produce tumors (176).

Stiles

suggests that this is a response to host mediated
growth-regulatory signals (177).

Tne "Nu" gene has been

successfully bre<i into a number of different genetic
backgrounds including BALB/C, C3H and C57/BL with a similar
effect in the acceptance of heterotransplants (178).
The nude mouse is apparently not without some defense
in terms of tumor metastasis, despite its T-cell and
humoral immunodeficiency.

Despite the growth of heterotrans-

planted tumors in the nude mouse, metastases are uncommon
(179).

Shimosato (180) noted metastases in only one of 22

transplanted human tumors, and Kullander (181) noted no
metastases in 10 tumors in nude mice.

Graham noted

metastases following injection of human T-cells into nude
mice with human malignant transitional bladder carcinomas
or prostatic adenocarcinoma (182).

Control animals not

receiving T-cells did not develop metastasis.

warner

reported a radiation sensitive non-T-cell surveillance
system against lymphoid tumors in the nude mouse (183).
Rygaard noted a considerable cytotoxic antibody response to
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heterograft stimulus, but not to allografts.

Yet,

heterografts were more readily accepted than allografts
(l84).

Cheers reported an augmented macrophage response in

the nude mouse (185).
Another interesting apparent paradox of the nude mouse
is the relative sparsity of spontaneous neoplasms.

Machado

noted one spontaneous neoplasm in over 1000 nude mice, in an
animal that had received a neonatal thymus transplant, and
Rygaard noted no neoplasms in over 11,000 nude mice (186).
This lack of malignant neoplasms in an animal lacking a
T-cell mediated immunologic system has been used as a
strong argument against the immunosurveillance theory as
proposed by Thomas.
C-type particles that have been repeatedly noted in
other mice strains are also present in the nude mouse.
Tralka reported a spontaneous lymphosarcoma in a nude mouse
with no C-type particles visualized in the primary tumor by
electron microscopy, but abundant C-type particles were
present in the in vitro cultured cells (187).

Tumors

developed in nude mice injected with tumor, but again no
C-type particles were noted in the transplanted

tumo~

suggesting some type of in vitro suppression or control of
virus expression in vivo.

Suzuki•reported the presence of

C-type particles in 6 of 9 human tumors transplanted into
the nude mouse.

Other human tumors could be readily

infected by co-cultivation (188).
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Growth of tumor in the nude mouse or other
immunodeficient or syngenic (to the tumor) animals is
unquestionably the most stringent criterion of
tumorigenicity for in vitro cultured cells.

The

development of the nude mouse is a significant advancement
in tumor biology.

CHAPTER III
MATERIALS AND METHODS
A.

CELL CULTURES
1.

PREPARATION OF PRIMARY CULTURES

Finely minced pieces of tissue, obtained from a biopsy
of a metastatic lesion in the right inguinal lymph node were
placed in complete medium, CM, (RPMI 1640, KC Biological;
Lenexa, KS;

o~

Grand Island Biological Co. supplemented with

15% fetal calf serum, 2 mM 1-glutamine (GIPCO), 100 U
Penicillin/ml (GIPCO), 100
and/or 100

g streptomycin/m1 (GIPCO),

g kanamycin/ml), and incubated at 37oc in 5%

C02. 95% air.

Fibroblast growth was antagonized by periodic

scraping of the flask under microscopic visualization with a
sterile cotton-tipped Pasteur pipette.

Repeated mechanical

removal of fibroblasts eventually allowed the development
of a confluent epithelial monolayer.

Cells were cultured in

25 cm2 (T-30) and 75 cm2 (T-250), Corning tissue culture
flasks (Corning Glass, Corning, N.Y.).

Feeding consisted

of CM (15 ml for 75 cm2, 5 ml for 25 cm2), when cultures
became acidic as indicated by a color change in the media
{phenophthaline) - generally every three days.

The

epithelial cell monolayer isolated was designated LT-2.
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2.

SUBCULTIVATION

Media was removed; the monolayers

wash·~~

with 5 ml of

ca++ and Mg++ free PBS; followed by 3 ml of 0.02% EDTA
(Mallincrodt); followed by incubation for 20 to 30 minutes
with 2 ml of 0.02% EDTA and 2 ml of 0.25% trypsin (GIPCO,
Grand Island, N.Y.).

Once the cells became detached 5 ml of

CM were added and the cells were centrifuged at 1200 rpm
for 10 minutes (400 x g.Model TJ-6, Beckman Instruments,
Fullerton, CA), resuspended in CM and placed in culture
flasks.

The flasks were labeled, dated, and the passage

number recorded.

A confluent 75 cm2 monolayer generally

yielded between 5-14 x 106 LT-2 cells.

During

subcultivation these cells were generally split into two
flasks with 15 ml CM each.
3.

CELL COUNT AND VIABILITY

Washed cells were obtained as above, suspended in 5 to
10 ml of complete media, and a 0.05 ml aliquot mixed with
0.05 ml of 0.4% trypan blue in normal saline (Matheson,
Coleman and Bell; Norwood, OH) and placed in a
hemocytometer counting chamber (Scientific Products; McGraw
Park, IL).

The viable (non-staining cells) were counted,

and the number of ce1ls/ml calculated as follows:

No.

cells counted/mm2 (at least 100) x 104 x dilution factor
No. cells/ml.

=
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4.

FREEZING AND TrlAWING

Cells from confluent flasks (75 cm2) were collected as
above, washed with ta++ and Mg++ free PBS, and resuspended
in 1 ml of CM with 10% DMSO (Fisher Scientific Co.;
Fairlawn, NJ).

Cells were placed in 1 ml vials (Wheaton

scientific, Millville, NJ) and sealed using a propane torch.
The cells were then slowly frozen (about 1°C/min.) in the
freezer core in the vapor phase (BF-5 biological freezer
assembly) of a LD-30 Linde liquid nitrogen container (Union
carbide Co., Linde Products, Indianapolis, IN) and stored in
the liquid nitrogen tank at -7ooc.
Cells were thawed by placing frozen vials in a water
bath at 37°C with shaking until melting occurred.

The

glass vial neck was cleansed with alcohol, broken and the
contents placed in 10 ml of pre-warmed (37oC) CM,
centrifuged (1200 RPM x 10 min.) and the pellet resuspended
in 10 ml of CM and placed in culture flasks.

Viability was

generally about 80%.
5.

PLATING EFFICIENCY

Monolayer cultures of LT-2 were harvested (T/E),
washed in CM, centrifuged, resuspended in CM and plated at 6
x 105 V. cells in 5 ml CM per flask in 25 cm2 tissue culture
flasks.

Cells were harvested at 2, 4 and 6 hour intervals

after washing x 2 with PBS without ca++ and Mg++, 2 ml
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versene followed by 2 ml Versene with 2 ml trypsin, incubated for 60 minutes at 37oc, neutralized with CM, centrifuged and an aliquot diluted 1:1 with trypan blue and
counted on a hemocytometer.
2, 4 and 6 hours.

The procedure was repeated at

A repeat experiment plated 4.25 x 106

LT-2 cells per flask, processed as described

abov~,

v.

except

that cells were incubated for 30 minutes at 37°C with or
without 100 mg/ml mitomycin C per flask; were harvested at
2, 4, 6 and 24 hours and counted.
6.

ACETO-ORCEIN STAINING OF CELLS

LT-2 cultures were tested for the presence of Mycoplasma by evaluation of aceto-orcein (GIPCO) staining of
Leighton tube (Wheaton Scientific, Millville, NJ) monolayers
subjected to hypotonic treatment as described by Fogh (189).
7.

OTHER CELL LINES AND STRAINS

Other cell lines and strains used in studies include:
AU-471, a human cervical carcinoma cell line obtained from
Doctor Walter Nelson-Rees, Naval Biomedical Research Laboratory, Oakland, CA; WI-38, a near diploid "normal" lung fibroblast cell strain obtained from The American Type Culture
Collection, Rockville·, MD; AT-264; a lung carcinoma cell
line kindly provided by Doctor Mira Menon, Hines
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veteran Administration Hospital, Chicago, IL; MS, a diploid
fetal fibroblast cell line cultured from an abortion ctt
Loyola University, Stritch School of Medicine, Chicago, IL;

sHK-21, a baby hamster kidney cell line kindly provided by
ooctor Eugene Major, Loyola University, Stritch School of
Medicine, Chicago, IL; LT-4, a normal human cell strain
isolated at Loyola University, Stritch School of Medicine,
Chicago, IL.

Cell numbers in all experiments represent

viable cells determined by trypan blue exclusion.
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TUMOH-HOST INTERACTIONS: IN VITRO
1.

ISOLATION OF LYMPrlOCYTES

Peripheral blood was collected by venipuncture into
heparin containing tubes which were immediately mixed.
Five (5) ml of blood were gently

laye~ed

on top of 3 ml of

Ficoll-Hypaque (Lymphoprep, Nyegaard Ans. Co.r Oslo, Norway)
in sterile tubes and centrifuged at 400 x g.
20 minutes (190).

(1400 rpm) for

The supernatant plasma was removed and

frozen, and the interface layer of lymphocytes was removed
with a Pasteur pipette.

The lymphocytes were washed with

ca++ and Mg++ free PBS, and re-centrifuged 1200 x g. for 5
minutes.

The cell pellet was resuspended in 5 ml of PBS

and an aliquot counted in a hemocytometer.
2.

DETERMINATION OF T AND 8 CELL POPULATIONS

Sheep red blood cells (SRBC) were stored at 40°C in
Alsevar's Solution (1:1), and used within 7 to 10 days of
delivery.

Before use, the cells were washed x3 and

adjusted to a 0.5% suspension in PBS.
T-RFC were measured:

Two populations of

the first termed the total T-RFC,

representing all T-cells in the peripheral blood; the second
called the active T-RFC, representing a subpopulation of the
total T-cells that 1) may have an active surveillance
function, and/or 2) be an index of cellular immunity (191).
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'1'

cells were evaluated by the formation of spontaneous

rosettes by mononuclear peripheral blood lymphocytes (PBL)
with unsensitized SRHC.

As a measure of the total T-RFC

population, 0.25 ml (5 x 105) PJHJ WPr"i~ ~'1iX·2d with 0.25 I'll 1>f.

o.5% unsensitized SRBC (a final SRBC: PBL ratio of 40:1) and
centrifuged at room temperature for five minutes at 200 x g,
and then incubated in an ice-water bath at 4-8°C for 60
minutes.

After the cell pellet was gently resuspended, a

drop of suspension was placed onto a hemocytometer and the
number of rosettes (3 or more SRBC surrounding a
lymphocyte) were counted.
duplicate and 200 or more

All tests were performed in
lymp~ocytes

were counted to

determine the percentage of total T-RFC.
To measure the active T-RFC, a modification of the
procedure of Wybran et al (192), was used:

0.25 ml (5 x 105

PBL) was mixed with 0.25 ml of 0.5% unsensitized SRBC and
centrifuged immediately at room temperature for five
minutes at 200 x g.

The cell pellet was gently resuspended

and a drop of the suspension was placed onto a hemocytometer
and the number of active T-RFC counted.
B-cells were determined by an
erythrocyte-antibody-complement (EAC) rosetting technique.
Five ml of a 5% solution of washed unsensitized SRBC was
incubated for 30 'minutes at 37oc with 5 ml of rabbit
anti-SRBC sera diluted 1/2500 in PBS.

The cells were
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~ashed

three times, and resuspended in 5 ml of PBS.

Five

ml of a 1/10 dilution of mouse sera was added, and the
suspension was incubated for 30 minutes in a 37°C
bath.

~ater

The sensitized SRBC were washed, and adjusted to a

o.5% final concentration in PBS containing 0.01 M Na3HEDTA.
For the B-RFC assay, 0.25 ml (5 x 105) PBL was ~ixed
~ith

0.25 ml of 0.5% sensitized SRBC, centrifuged at 200

~

g. for two minutes at room temperature, and then incubated
for 30 minutes in a 37°C water bath.

The cell pellet was

resuspended by vigorous mixing, and the B-RFC were counted
as described before.

When unsensitized SRBC were tested as

controls, no or few rosettes
3.

w~re

formed.

LYMPHOCYTE-MEDIATED CYTOTOXICITY (LMC)

LMC of patient and control lymphocytes versus cultured
tumor cells was determined by the chromium release assay
(CRA) described by Brunner, et al (193).
Briefly, 5 x 105 patient or control lymphocytes in 0.5
ml HEPES buffered complete medium with 15% fetal calf
serum, patient plasma or control plasma were incubated with
104 51cr-labeled tumor cells in 0.5 ml complete medium with
the corresponding serum or plasma (50:1 effector/target) 5
to 7 hours at 37°C in a C~2 incubator.

Total count and

blank tubes contained labeled tumor cells in a 1 ml complete
medium with the appropriate seru1n or plasma without
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lymphocytes: 0.1 ml 10% Triton X-100 was added to each total
count tube.-

All determinations were made in triplicate or

quadruplicate.
After incubation, tubes were centrifuged at 400 x g.
for 10 minutes and an aliquot of the supernatant was assayed
for radioactivity in an automated gamma spectrophotometer.
Lymphocyte-mediated cytotoxicity of samples was determined
by the expression:
CPM Sample - CPM blank

-------· .. -·.- -------%LMC =

X

100.

CPM total count - CPM blank

4.

DETERMINATION OF LYMPHOBLAST 'rRANSFORMATION

Lymphocytes were obtained from heparinized blood as
described above and 5 x 105 of these cells were incubated
in complete medium with 15% fetal calf serum, patient

.

plasma or control plasma with 0.1 ml PBS, phytohemagglutinin
(PHA-P, Difco Labs; full-strength or 1:10 dilution), a cell
KCl extract (100 meg or 1 meg), or 104 mitomycin C-treated
LT-2 cells at 37°C in a C02 incubator.
After 48 hours incubation 1~Ci 3H-thymidine (2 Ci/mM,
New England Nuclear Corp.) was added to each tube.

After an

additional 24 hours incubation, the reaction was stopped by
transferring the tubes to a refrigerator, DNA was
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~recipitated

with trichloroacetic acid (TCA), the

precipitate was washed with PBS, centrifuged, and
resuspended in NCS solubil izer ( Amer.;3ha;n/Searle Corp.,
Arlington Heights, IL) and the resultant solution was
transferred to scintillation vials in 10 ml Bray's solution
with Triton X-100.

Radioactivity in the vials was assayed

in a Packard Tri-Carb automatic refrigerated liquid
scintillation counter.
Lymphoblast transformation was ascertained from the
relative 3H-thymidine uptake by lymphocytes, represented by
a stimulation index calculated from the ratio of CPM in
sample vials to CPM in PBS control vials.
to be invariable among samples with 5%.
assayed in triplicate or quadruplicate.

Quench was found
Samples were
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c.

TUMOR-HOST IN'rERATIONS:
•

1.

>

••

-

IU VIVO
••

-

•

- - -

SKIN TESTS

General and specific delayed type hypersensitivity of
the patient was determined by intradermal injection on the
flexar aspect of the forearms of the patient with 0.1 ml
streptokinase/streptodornase (50 units with respect to
streptokinase in 0.1 ml (Lederle Lab., Pearl River, NY),
dermatophytin (0.1 ml of a 1/30 dilution, Hollister-Stier
Lab., Spokane, WA), dermatophytin-0 (0.1 ml of a 1/100
dilution, Hollister-Stier Lab.), PPD (0.1 ml intermediate
strength, Parke Davis, Detroit, MI), mumps (0.1 ml, Eli
Lilly, Indianapolis, IN), and 0.1 ml LT-2 KC1 extract
(sterilized by filtration;
100 ,;cg and lAg protein/0.1 ml).

DNCB (2000 and SO_)A..g in

acetone, Eastman Organic Chemical Co., Rochester, NY)
challenge was accomplished by allowing test samples to
evaporate on a 25 to 30 mm3 area of skin on the forearm.
At least 10 mm of induration at 48 hours after challenge
with microbial antigens was considered a positive skin test
response.
14 days.

For DNCB the reaction was evaluated by retest at
A flare at both the

2000~g

and 50Mg sites was

scored as a 4+ reactivity; at only the 2000

~g

a positive flare to only a repeat application of

site as 3+;
SO~g

the opposite forearm evaluated at 48 was scored 2+.

In

on
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practice, a 3+ or 4+ reactive score is considered normal
(positive DNC3 reaction).
2.

PREPARA'riON Of KC 1 EXTHAC'rS

L'l'-2 monolayers consistinlJ vf i>~~tween 6 to 14 x 106
cells were harvested using either 3M KCl or 0.081% EDTA in
25 mm HEPES buffer, followed by centrifugation and
resuspension in 3M KCl.

The KCl suspensions were rocked at

4oc overnight and then centrifuged at 163,000 x g. for 60
minutes at 4°C in a Beckman Ultra-centrifuge.

The

supernatants· were filtered, concentrated (PM-10 membranes),
dialyzed against three changes of 200 volumes of normal
saline at 4°C for 24 hours, centrifuged at 1,500 x g. for 20
minutes at 4°C, lyophilized and reconstituted in 2 ml of PRS
and the protein concentration measured by the Lowrey method.
The extract was filtered through 0.2

~pore

filters and stored in glass vials at -75°C.

size Gelman
Skin testing

consisted of the intradermal injection of 0.1 ml of the
above preparation, and 0.1 ml of PBS on the volar skin of
the forearm.

The autologous tumor skin test was read at 48

and 72 hours.
3.

BCG IMMUNOTHERAPY

The patient received four BCG immunizations over a five
month period, commencing 46 days after the lesion in the
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right inguinal lymph node was biopsied.

For the first

immunization, 3 to 5 x 108 lyophilized viable Chicago
strain organisms were reconstituted with 0.5 ml sterile
saline and 0.2 ml (1.2-2.0 x 106 viable organisms} was
injected into one site of the lesion.
Three additional immunizations were given,
administered at one month intervals following the first
injection.

For the second and third immunizations, the

contents of one ampule were reconstituted with 1 ml sterile
water followed by a 100-fold dilution; 0.2 ml (0.6-1.0 x 106
viable organisms} was injected intralesionally, in six
sites for the second immunization and in one site for the
third immunization.

For the final immunization, one ampule

was reconstituted with 0.5 ml sterile water and this
suspension was spread over an area of the anterior right
thigh:

72 puncture wounds were made in this area by

applying a 36-tine instrument to two adjacent sites.
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o.

CELL CHARACTERIZATION AND TUNOR PROPERTIES
1.

ELECTRON MICROSCOPY

A portion of a nude mouse nodule (see below) and cells
harvested from monolayer cultures were fixed in 2.5%
glutaraldehyde in PBS at 4ooc overnight and post-fixed in
osmic acid one hour at room temperature.

The fixed

specimens were then carried through graded alcohol
dehydration and embedding in Araldite.

Electron microscopy

procedures were performed by Doctor Emilio Orfei,
Department of Pathology, .Loyola University Medical Center,
Chicago, IL.
2.

KARYOTYPING

Karyotyping was done by a modification of the method
of Hsu (194).

Briefly, colchicine 1o-6M (BBL) in CM was

added to an LT-2 monolayer and incubated for five hours at
37°C.

An EDTA-HEPES-harvested single-cell suspension was

counted, centrifuged at 300 x g. for 10 minutes and
resuspended in hypotonic KCl (71mM) at a concentration of
104 cells/ml.

Following a 20 minute incubation at 37oc the

cells were again centrifuged and resuspended in a 10 ml
freshly prepared absolute methanol-glacial acetic acid
(3:1).

The cells were centrifuged, the supernatant

decanted, the pellet left overnight at 4oc, and resuspended
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in a 2 ml methanol-acetic acid fixative.

The cell

suspension was dropped onto slides, framed, allowed to dry,
and stained with Giemsa (for 7 to 9 minutes).

Mitotic

figures were observed and photographed through a Zeiss
microscope at 1000 x magnification.

3.

DETERMINATION OF GENERATION TIME

Two confluent 75 cm2 culture flasks (approximately
17.6 x 106 cells, 96% V.) were harvested, washed and
resuspended in CM and distributed equally among twenty 25
cm2 culture flasks (8.5 x 10S cells per flask).

Adherent

cells were harvested from quadruplicate flasks after 27
hours, 46.5 hours, 72 hours, 97 hours and 118 hours.

The

single-cell suspension was centrifuged at 300 x g. for ten
minutes and the pellet was resuspended in 0.5 ml phosphate
buffered saline (PBS), diluted with an equal volume of 0.4%
trypan blue stain in normal saline and counted in a
hemocytometer.

The log of the number of viable cells (N)

was plotted against time in hours.
log N=

0

-~~ 1 t

+log No.

Based on the relation

The doubling time (to) during the

logarithmic growth phase of the cells was determined from
the slope (0.301/to) of the linear growth curve.
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4.

TIME-LAPSE"CINEMATOGRAPHY

Time-lapse cinematography was done using a Nikon model
M inverted phase

co~trast

microscope with Matthias

time-lapse control unit and Bolex camera and incubation
chamber with heater and a Precision Scientific air/C02
blender.

This equipment was used courtesy of Doctor George

Willbanks, Chairman, Department of Obstetrics and
Gynecology, Presbyterian-St. Lukes Medical School, Chicago,
IL).

Kodak Plus-X reversal film 7276 (400ft., 16mm-B

wind) was exposed for one second at two frames per minute
at 200 x magnification, (about 40.18 frames/ft.).

Two

separate filmings of LT-2 and one of AU-471 were done.
5.

SATURATION DENSITY

L'f-2, AU-471 and WI-38 monolayer cultures were
harvested; washed and resuspended each in 5 ml PBS; the
cells counted, centrifuged, and adjusted to a concentration
of 5 x 105 cells/ml' in RPMI-1640 with 15% FCS; and plated in
24 well cluster dishes, Costar, (0.1 ml/well with 5 x 104
viable cells).

Only the inner eight wells of each 24 cell

cluster plate were used for culture.
filled with sterile H20.
an area of 2.011 cm2/well.

The outer wells were

Each well has a 16 mm diameter or
Three cultures (24 total wells)

were used for each cell type.

Cultures were fed

periodically with CM (1 ml/well).

One well from each of
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three plates was harvested serially, and the cells counted,
and scored for viability.

The cell density was expressed

as the number of cells per cm2.
6.

DENSITY DEPENDENT INHIBITION OF CELL DIVISION OF
L:r_-:_2, AU-471 and WI-38_ CELL LINES

Eighteen Leighton tubes with cover slips (Wheaton
scientific, Millville, NJ) were autoclaved.

Three groups

of six tubes each were seeded with 5 x 104 viable cells per
tube with LT-2, AU-471 and WI-38.

When the cover slips were

noted to be partially confluent, two tubes from each set
were harvested, fixed in acetone for five minutes, stained
with aceto-orcein for five minutes and counterstained with
Giemsa for five minutes.

The remaining four cultures were

then refed with colchicine 10-6 M in CM, and two tubes
harvested at 24 and 48 hours, fixed and stained as above.
Photographs were taken of appropriate areas to locate the
position of dividing cells in moderate sized colonies.
7.

SURFACE ANTIGENS:

ABH

LT-2 was harvested (Pas. 30, 92% V.), washed, counted
and resuspended at 5 x 106 cells/ml.

Twenty-five ~1

aliquots were mixed with 0.025 ml of an agglutinogen
consisting of:
substance.

Anti-Rho, Anti-RhC, Anti-A, Anti-B, Anti-H

Tne antiseras and cells were incubated at both

63
2 soc and 32°C for ten minutes.

Controls with LT-2 and 0.025

ml of PBS were also used to assay for "spontaneous" agglutination.
8.

HETEROPHILE ANTIGEN

LT-2 monolayers were washed with PBS without Mg++ and
ca++ and x3 with 5 ml of Versene.

They were incubated with

versene until cells became detached or harvested in a routine manner (as described above) using trypsin and EDTA.
They were washed with PBS, centrifuged and resuspended at 5
x 106 cells/ml in PBS with Mg++ and ca++.

AU-471 was pro-

cessed similarly.
Infectious mononucleosis positive and negative human
serum was obtained (courtesy of Doctor Ken Thompson, Loyola
University Clinical Microbiology Laboratory, Chicago, IL),
and normal rabbit serum were mixed (0.025 ml).

Each were

incubated at 7oc for 1 and 2 hours, and evaluated for agglutination.
9.

ASSAY FOR CEA AND hCG

Two days after nutrient media changes, spent media from
LT-2 cultures (subsequently harvested with 0.01%
Na2EDTA/0.125% trypsin for counting of single cells) was
filtered through 0.2 micron pore size Nalgene disposable
filter units.

Most of this filtered spent media was con-

centrated to approximately 1/Tth or 1/4th of its original
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volume through a PM-10 membrane in an Amicon ultrafiltration
unit.

An equal quantity of unused complete media was

treated in an identical fashion.

Sa~ples of spent media,

7-times concentrated spent media, 14-times concentrated
spent media, and corresponding samples of unused complete
media were assayed for CEA, hCG, and/.1-hCG-subunit.
Carcinoembryonic antigen (CEA) in the above samples
was determined by the Foster G. McGaw Hospital Nuclear
Medicine Department, Chicago, IL, under the direction of
Doctor Robert Henkin, using the CEA-Roche test kit (Roche
Diagnostics, Nutley, NJ).

Radioimmuno-assay for hCG/LH

and/.1-hCG-subunit was performed by the John I. Brewer, Choriocarcinoma Research and Treatment Center, Northwestern
University Cancer Center, Northwestern University Medical
Center, Chicago, IL.

The rate, r, of ~-hCG or CEA produc-

tion (ng/106 cells/day) by LT-2 was approximated as

r

=

(ng/ml assayed}(concentration factor) x 10 ml/flask
(3 x 106 cells/flask average) x 2 days

10.

SERUM DEPENDENCE

Serum dependence was evaluated for LT-2, AU-471 and WI38.

Two separate experiments were performed.

In the
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first experiment LT-2, AU-471 and WI-38 were plated in 10%,
1%, 0.01% and 0% FCS at 1.5 x 105 viable cells per well in
24 cluster plates (Costar, Cambridge, MA) in triplicate.
only the inner eight wells of any given 24 well plate were
used.

Duplicate plates with each cell type were plated in

15% FCS, incubated overnight, and the media aspirated.
culture wells were washed once and then refed with CM with
the varying concentration of FCS as noted above.

Plates

were harvested (T/E) four days later, and cells counted
using a Coulter counter (Coulter Electronics Inc., Elk Grove
Village, IL).
A similar experiment was repeated using triplicate
cultures plated in the appropriate serum concentration
using AU-471 and LT-2 with cultures harvested six days
after plating and then counted on a hemocytometer.
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GROWrH IN SOFT AGAR:
1.

ANCHORAGE -INDEPENDENT
· - - - - - - - -GRO~~H
----

EPIGENETIC FACTORS

Tumor cell growth in soft agar is a commonly used test
for in vitro malignancy.

It is based on the observation

that nonmalignant epithelial cells do not grow in soft agar
or in suspension, but require attachment to a surface
before cell division will occur.

Therefore, growth in soft

agar (anchorage independence for cell division)

is an

"abnormal" property for a cell, and suggests a malignant
biological potential.
Soft agar assays were adopted from protocols of
MacPherson and Montagnier (195) and also from Major and di
Mayorca (196).

Briefly, a "feeder agar" consisting of 0.5%

Difco Bacto agar in RPMI-1640 with 10% tryptosephosphate
broth (GIPCO), and antibiotics (consisting of either
penicillin, 100 units/ml and streptomycin
kanamycin

100~g/ml

or gentamycin

100~/ml

100~g/ml)

or

was poured

into 60 mm x 15 mm petri dishes (Flacon No. 1007) and
allowed to solidify.

Over this "hard" or "feeder agar" was

poured 1.5 ml of 0.33% "soft agar" (prepared as for 0.5%
agar above, but with less agar).
in the soft agar.

Test cells were suspended

The cultures were maintained at 37°C in

an atmosphere of ·5% C02, 95% air for 3 to 4 weeks, until
visible colonies were scored and the test terminated.
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2.

SOLUBLE STIMULANTS OR INHIBITORS

Anchorage independent growth in soft agar suspension is
a frequently used
noted above.

i~

vitro criterion for malignancy as

Yet, under usual conditions LT-2 would not

clone in soft agar, but did fulfill most other criteria for
malignancy including:

continued growth in culture, growtn

and tumor formation in nude mice, abnormal karyotype, (see
below).

Experiments were performed to determine whether

LT-2 produced a soluble inhibitor that would prevent the
growth of other tumors in soft agar culture, and conversely
determine if. growth in soft agar could be stimulated by a
soluble substance from tumor cells that grow well in soft
agar as manifest by a high soft agar cloning efficiency.
LT-2, AU-471 and WI-38 were used in these experiments.
3.

THE EFFECT OF LT-2 ON THE SOFT AGAR GROWTH AND
CLONING OF AU-471

In four

experi~ents,

with mitomycin C

viable LT-2 cells were treated

(100~g/ml

CM), and incubated for 40 min-

utes at 37°C with shaking, washed 2 times with PBS and resuspended in CM.
served as

11

These mitomycin C treated LT-2 cells

feeder cells" to test for the presence of soluble

factors that might stimulate or inhibit cloning in soft
agar.

Mitomycin C is an antibiotic produced by Streptomyces

Verticillatus and is converted in a cell by reductive acti-
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vation to an alkylating agent that selectively inhibits DNA
synth~sis

(197).

AU-471 served as test cells, and were

plated at 5 x 102 or 2 x 103 cells per plate in soft agar
in different experiments and mixed with increasing concentrations of LT-2 "feeder" cells (1 x 104 to 1 x 105 LT-2).
AU-471 controls were plated at the appropriate concentration without "feeder" cells to serve as a standard control, and LT-2 mitomycin C or nonmitomycin C LT-2 without
AU-471 served as negative controls.

LT-2 preplated onto the

bottom of 60 mm culture plates with agar poured on top of
the culture served as a LT-2 growth and viability control,
and were scored negative.or positive for growth and viability.

AU-471 test plates and controls were scored on two oc-

casions.
Two additional experiments were done using untreated
LT-2 (non-mitomycin C) as "feeder" cells taking advantage of
the fact that LT-2 will not clone in soft agar.

In one ex-

periment, ten plates of 2 x 103 and 2 x 104 viable LT-2
cells per plate (Pas. 21, 85% V.) were used as controls,
and were also co-cultivated with AU-471

(AU-471:LT-2 at 1:1

and 1:10 cells per plate (2 x 103 AU-471:2 x 103 LT-2 or 2 x
103 AU-471:2 x 104 LT-2).
and 24.

Colonies were scored at day 14

The other experiment used ten plates each of 2 x

103 and 2 x 104 viable AU-471 per plate (Pas. 121, 90% V.)
co-cultivated in soft agar with 1:5 or 1:50 ratio of AU-
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471:LT-2 per plate.

Controls of ten plates of 2 x 103 and 2

x 104 AU-471 without LT-2 and 105 LT-2 (Pas. 18, 99% V.)
without AU-471 served as an LT-2 control.
4.

EFFECT OF AU-471 ON SOFT AGAR GROWTH OF AU-471

Since an increase in cloning efficiency or "feeder efteet" was noted in LT-2:AU-471 and also in WI-38:AU-471 cocultivation experiments, the effect of mitomycin C treated
AU-471 on the cloning efficiency of untreated AU-471 was
evaluated.

The experiments were performed using 5 x 102

(Pas. 112, 87% V.) and 2 x 103 (Pas. 126, 89% V.) AU-471
test cells co-cultivated in soft agar with increasing concentrations (2 x 103 to 1 x 105 viable cells in different
experiments) of mitomycin C treated AU-471 "feeder" cells.
Controls consisted of untreated AU-471, mitomycin C treated
AU-471
5.

(no untreated cells) and pre-plated AU-471.
EFFECT OF MITOMYCIN C TREATED AU-471 CO-CULTIVATED WITH LT-2

The reverse experiment used five plates each of 2 x 104
and 1 x 105 mitomycin C treated AU-471 "feeder" cells (Pas.
122, 84% V.) with a comparable number of untreated LT-2
cells (Pas. 28, 78% V.).

Controls consisted of five plates
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each of 2 x 104 and 1 x 105 LT-2 without AU-471 and 2 x 104
and 1 x 105 mitomycin C treated (100.,u.g/ml CM for 40 minutes
at 37oc with shaking) AU-471.
6.

EFFECT OF WI-38 ON 'l'HE SOFT AGAR GROW'fH AND
CLONING OF AU-471

A similar "feeder" experiment was done in order to
determine the stimulatory or inhibitory effect of
co-cultivation of varying concentrations of "normal" cells
on the soft agar cloning efficiency of AU-471, to serve as
a "normal" control.

v.)

Five plates each of WI-38 (Pas. 26, 95%

with cell concentration of 2 x 104 and 1 x 105 viable

WI-38 cells per plate were co-cultivated with 2 x 103 viable
AU-471

(Pas. 121, 84% V.) in soft agar.

scored on days 14 and 22.

Colonies were

Cloning efficiency was compared

to ten plates of 2 x 103 control AU-471 per plate.

Five

plates each of WI-38 at 2 x 104 and 1 x 105 without AU-471
served as controls.
7.

FIELD COUNT EXPERIMENTS ANO THE EFFECT OF
MITOMYCIN C AND CYTOCH-AL-AS-{N- B- ON -L'f=--2GROWTH AND
-- ·---····-- - .
CLONISG IN SOFT AGAR
---------~

Since LT-2 had been noted during time-lapse
cinematography to be highly motile in tissue culture,
experiments were performed to determine whether LT-2 was
dividing in agar (or agarose), and the daughter cells
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moving apart forming single
into clones.

c~lls

rather than developing

To test this hypothesis, LT-2 was plated in

agar suspension (or agarose), and the number of cells per
high power microscopic field (150x) were scored for five
random fields in each of five agar culture plates.

Similar

"field counts" were repeated on two additional occasions one
and two weeks later.
One experiment consisted of five plates of 4 x 104
viable LT-2 and five control plates of
with field counts on days 1, 8 and 23.

100~g

mitomycin C/ml

Additional

experiments were done to evaluate the effects of
cytochalasin B on soft agar growth and cloning of LT-2.
Cytochalasin B is known to inhibit cell movement,
phagocytosis, and under appropriate conditions may produce
cell enucleation.

The probable mechanism of action is

through disruption of microfilaments (198).

Cytochalasin B

was used at concentrations nE 1..)-l!J/ml and 5 _,4-<gjml CM and
compared with similar field counts of the same plates at
different time periods and/or to control plates of untreated
or mitomycin-treated ( 100 ).J.g mitomycin C) LT-2 agar plates.
Five

~g

cytochalasin B

has been shown to cause cell

cytoplasmic retraction of spread cells with cell rounding

.

and inhibition of cell movement (199).

8.

THE EFFECT OF NEGATIVE AND POSITIVE
ON THE CLONING EFFICIENCY OF LT-2
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CHARGED IONS

Heparin and other highly negatively charged molecules
have been reported to reduce cloning efficiency in soft
agar.

Cell membranes are negatively charged and contact be-

tween normal cells generally results in contact inhibition
of cell division.

That ions in contact with the cell mem-

.
brane in soft agar might result in a form of "contact inhibition" preventing cell division was considered.

This hy-

pothesis was evaluated using agarose. Agarose is a purified
form of agar with many of the negatively charged ions removed.

Diethylaminoethy~

dextran which complexes with posi-

tively charged ions was also used to evaluate the effects of
decreased positively charged ions.
The concentration of the agar is important in evaluating anchorage independence since even "normal" fibroblasts
will sometimes produce colonies in agar when the concentration of the agar is increased.

Agar concentrations of

0.33% give a semi-solid consistency.

Apparently, cell

growth and colony formation results from giving the cells a
more solid surrounding for contact with the cell membrane.
The consistency of pure agarose was noted to be somewhat different from that of agar (0.33% agar has a
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semi-liquid consistency, but .033% agarose has a more solid
consistency).

Dilutions of agarose were made and their

consistency (solid to semi-solid to'liquid) determined at
various concentrations of agarose.

A consistency of

agarose of about 0.275% was chosen for the top agar with a
feeder layer of 0.300% agarose giving a
to 0.3%/0.5% agar.

consisten~y

similar

Other experiments used 0.33% top agarose

with 0.5% feeder agarose giving a more solid consistency
similar to experiments with 1% DIFCO agar, or 0.1% top
agarose with 0.15% bottom agarose giving a much more fluid
agarose than the standard 0.33% "soft agar."
The effect of cloning LT-2 in "soft agarose" was
evaluated by plating five 60 mm TC plates with 1 x 105
viable LT-2 cells per plate (Pas. 29, 80% V.) in 1.5 ml of
0.275% agarose with 5 ml of 0.3% bottom or feeder agar.
Five comparable control plates were preplated and overlayed
with ag arose.
One arm of the experiment combined both agarose and
DEAE and consisted of three 60 mm TC with 1 x 105 viable
LT-2 cells per plate (Pas. 31, 44% V.) with

22~g

DEAE per

ml top agar in agarose.
A "hard agarose" experiment consisted of five 60 mm TC
plates with 2 x 104 viable LT-2 per plate (Pas. 31, 44% V.)
in 0.33% top agarose with 0.5% bottom agarose.

Two

additional 60 mm TC plates were plated with 1 x 105 viable
LT-2 as above.
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A "softer" agarose experiment used 0.10% top agarose
with 0.15% bottom agarose.

Four 60 mm TC plates were each

plated with 0.7 x 10S viable LT-2 (pooled flasks, 27% V.).
comparable preplated viability controls were overlaid with
agarose.
Two experiments were done to evaluate the effect of
oEAE on the soft agar cloning efficiency of LT-2.

These

experiments consisted of five 60 mm TC plates each with 1 x
10S viable LT-2 cells (Pas. 30, 38% V.) and (Pas, 23, 60%

v.)

plated with

30~g

DEAE per ml soft agar as test plates

with five comparable untreated control plates.

In addition

five plates were preplated with LT-2 as viability controls.
9.

EFFECT OF HEPES BUFFER ON LT-2 GROWTH IN SOFT
AGAR

The effect of HEPES buffer in cloning efficiency of
LT-2 was evaluated using five 60 mm TC plates each with 1 x
105 viable LT-2 (Pap. 31, 53% V.) with 30 mm HEPES with
scoring for colony formation on days 16 and 23.
10.

EFFECTS OF CYCLIC GMP ON LT-2 GROWTH IN SOFT
AGAR

The effects of cyclic dibutyryl GMP (cGMP) on cloning
of LT-2 in soft agar was evaluated using five 60 rnm TC
Plates each with 1 x 105 viable LT-2 per plate (Pas. 32, 62%
V.) with concentrations of cGMP of 10-9M, 1o-10M, 1o-11M
With scoring for colonies on days 16 and 23.

11.
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THE EFFECT OF· ENZYME TREATMENT OF LT-2 ON CLONING
IN SOFT AGAR

The effect of digestive enzyme treatment of membrane
molecules of LT-2 on the cloning efficiency using
neuraminidase trypsin and a variety of carbohydrases was
evaluated.
a.

NEURAMINIDASE

A monolayer culture of LT-2 was harvested, (T/E),
washed with PBS and the cells resuspended in 4 ml of PBS
without Ca++ and Mg++ (4.35 x 106 cells; Pas. 31, 85% V).
Two milliliter aliquots were placed in separate tubes,
centrifuged and resuspended in 0.2 ml of PBS or PBS with 60
units neuraminidase/ml and incubated with shaking for 60
minutes at 37oc.

Two 60 mm culture flasks with 1 x 105

viable non-treated LT-2 (44%
agar served as controls.

v.

post-incubation) in soft

Three cultures contained .91 x

105 neuraminidase treated LT-2 (53% V. post-incubation) and
three additional soft agar cultures contained .91 x 105
viable LT-2 treated with neuraminidase as above, but with
the addition of 0.22fog DEAE per/ml of soft agar.

All

neuraminidase cultures also contained 50 units neuraminidase
per/ml of soft agar.
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b.

CARBOHYDRASES

A soft agar experiment was performed in order to determine the effect of a variety of enzymes specific for carbohydrate substrates on anchorage independent growth.

LT-2

was harvested (T/E), neutralized with CM, centrifuged,
counted (Pas. 24, 71.4% V.) and resuspended in 2 ml of PBS
(without ca++ or Mg++), passed through a 50 ~mesh, counted
on a hemocytometer with trypan blue and resuspended at 5 x
106 viable cells per ml.

Fifty microliter aliquots (2.5 x

105 viable cells) were incubated at 37°C for one hour with
0.2 ml of either:

0.6 or 6 mg B-glucosidase, 0.55 mgc<-D-

glucosidase, 0.75 and 0.075 mg chitinase, 1.25 units (2.75
mg/ml) 0(-L-Fucosidase, 3 units (18 units per mg)o<D-mannosidase or a mixture of all of the above enzymes.
bated mixtures were plated in soft agar.
tions in top agar were 1 ~g glucosidase,
cosidase, 1 and

10~g

chitinase,

mannosidase per ml; and

l~g

0.25~g

The incu-

Final concentraand

10~g

B glu-

L Fucosidase; 1 ~

of a mixture of all of the

above per ml top agar.
12.

LT-2:AU-471 CO-CUL1'IVATION: EFFECT OF CELL CONTACT AND CELL LYSIS OF MITOMYCIN C AND UNTREATED
LT-2 C£LLS

The effect of LT-2:AU-471 cell contact or LT-2 cell
lysis was compared in mitomycin C treated and untreated LT2 feeder cells.

Six plates of AU-471 with 2 x 103
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viable cells per plate were used as a control to determine
cloning efficiency.
with:

Three plates were each co-cultured

2 x 103 viable AU-471 and 103 or 105 untreated or

mitomycin C treated LT-2

(100~g/ml

incubated for 40 min. at

370C); 103 or 105 untreated or mitomycin C treated LT-2
pelleted with AU-471 responder cells and then incubated for
60 min. at 37oc in 5% C02; 103 or 105 untreated or mitomycin

c

treated LT-2 lysed by freeze thawing (zero percent

viability as checked by trypan blue exclusion).
controls consisted of 10S

v.

Two prelate

LT-2 or 1.2 x 103 V. AU-471

overlaid with 1.5 ml of 0.33% soft agar.

A growth control

for LT-2 consisted of 10S LT-2 plated alone in soft agar
without AU-471.
A repeat experiment was done as above except 104 and
10S LT-2 cells were used instead of 103 and 10S in each of
the arms of the experiment as described above.
13.

CONDITIONED MEDIA

Filtered

(0.2~

Nalgene) conditioned media taken from

partial confluent monolayer cultures of LT-2 and AU-471 at
24 hours and from MS at six days was used as "feeder" media.
Five cultures of 1 x 103 viable AU-471

(Pas. 125, 83% V.)

without conditioned media served as controls.

Five plates

each with 30% of .15% conditioned media from AU-471

(Pas.

125), LT-2 (Pas. 50), and MS (Pas. 6) were substituted for
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fresh media and were added.to 1 x 103 viable AU-471 cells in
soft agar.

Concentrations of tryptose phosphate broth,

fetal calf serum and total media content (RPMI-1640) were
kept constant.

Two preplate controls of 1 x 103 viable

AU-471 without conditioned media or with 30% conditioned
media from AU-471, LT-2 or MS were also done.

A total of

43, 60 mm soft agar cultures were done.
14.

PROTEIN EXTRACT FROM AN ANCHORAGE INDEPENDENT
CELL LINE

Monolayer cultures of AU-471 were treated with 10 ml
of 3M KCl for 10 minutes at 37°C; the flask content
decanted into 50 ml tubes and rocked overnight at 4°C;
centrifuged at 25,000 x g. for 90 min. at 4°C.

The two

supernatants were pooled and concentrated using an Amicon
PM-10 membrane, the retentate dialyzed with normal saline x
3, centrifuged at 1500 x g. at 4°C for 120 min. and filtered
using 0.2 Nalgene

f~lters.

using the Wadell method.

Protein content was estimated
Three plates each with 1 x 10

viable LT-2 (Pas. 43, 84% V.) were mixed with 20, 310 and
1,000~g

per plate of the protein extract with 12% PBS.

Two AU-471 plates of untreated LT-2 controls and two
preplate cultures were also done.

A comparable set of

cultures (13 plates) were done without FCS.
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15.

CELL CLUMPS IN SOFT AGAR

L'r-2 had been noted to be relatively sensitive to
plating at low cell densities.

Therefore, studies were done

in order to determine if cell-cell contact was necessary to
initiate or stimulate anchorage independent growth in soft
agar.

Five separate experiments were performed consisting

of 30 cultures and 8 preplate controls to evaluate cell
viability.

Two culture plates contained no cells to insure

that as the agar dried that precipitants did not form
visible clumps in agar.

105 viable LT-2 cells were plated

in each culture as previously described, except that cells
were not passed through 100 micron mesh filters to
eliminate clumps.

Small clumps of cells noted in the agar

were circled and photographed serially.

Photos were then

compared to evaluate for enlargement of cell clumps
indicating growth in soft agar.
16.

FIBRONECTIN

The effect of fibronectin (FBN) and antifibronectin on
anchorage independent (soft agar) cell growth and cloning
was evaluated.

The cancer cell lines AU-471

(clones in

soft agar) and LT-2 (no clones in soft agar) were used.
Three "normal" cell 1ines were also used:

BHK-21 (clones

in soft agar), WI-38 and MS (no clones in soft agar).
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AU-471 was used to evaluate the effects of FBN on the
cloning efficiency of a malignant tumor cell line that
demonstrates anchorage independent growth.
experiments were done.

AU-471

Four

(Pas. 121, 126, 127)

monolayer cultures were harvested, washed, passed through
an

80~nylon

mesh and counted.

Cells were divided into two

aliquots and incubated for 30 minutes at 37°C with
per ml FBN or PBS control in 2 ml volumes.

100~g

The cells were

then centrifuged, resuspended in PBS and four cultures were
each plated with 2 x 103
per ml soft agar.

v.

AU-471 in 100 g/ml FBN or PBS

One or two preplate cultures with or

without FBN were also used as cell viability controls.
Colonies were scored twice, generally at 2 and 4 weeks.
The effect of FBN on soft agar cloning of LT-2 was
cloned as an example of a malignant cell line (defined by
tumor production in nude mice) that does not demonstrate
anchorage independent cloning.
using LT-2 (Pas. 49', 41 , 61 ) •

Three experiments were dorie
Monolayer cultures were

harvested, washed, passed through 80 A. nylon mesh cultures,
counted and incubated for 30 minutes at 37°C with
FBN or PBS in 2 ml volumes.

100~g

of

The cells were centrifuged,

resuspended in PBS and four plates each were seeded with
x 104

v.

cells in 100~g per ml FBN or PBS of soft agar.

One or two preplates were also done and cultures scored as
above.
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The effect of FBN on soft agar cloning of BHK-21 was
done using BHK-21 as an example of a "benign" cell line
that does demonstrate anchorage independent growth.

The

experiments were done using BHK-21 as described above.
The effects of FBN on soft agar cloning of WI-38 and
MS were done using these cell lines as examples

o~

"benign"

cell lines that do not demonstrate anchorage independent
growth.

The experiments were done as described above.

Heat inactivated (57oc for 60 minutes) Goat
antifibronectin sera (GAFS} was used to determine the effect
on anchorage independent growth and cloning of AU-471 and
BHK-21.

AU-471

(Pas. 123) and BHK-21 cells were harvested,

washed, passed through an 80

M....

nylon mesh, counted and

scored for viability, and 4 plates each with 2 x 103

v.

AU-471 or BHK-21 were seeded in soft agar with GAFS or
normal goat sera (heat inactivated as above} at the same
protein concentration (9.0 mg protein per culture).
Additional controls consisted of four plates each of AU-471
and BHK-21 in soft agar without treatment and six preplate
controls seeded at 8 x 105

v.

cells for cell viability (one

preplate without treatment, one with FBN and one with NGS
each for AU-471 and BHK-21}.

Cultures were scored for

colonies at 14 days a'nd 27 days. ·
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17.

CELL SUBSTRATUM ADHERENCE AND ANCHORAGE
INDEPENDENCE

Monolayer cultures of AU-471 show piling up of cells
(lack of contact inhibition} that results in high cell
saturation densities (cell/cm2} in confluent cultures.

Many

cells can be found floating in the media even in cultures
of cells that grow as strict monolayers without piling up of
cells (low saturation density}.

Evaluation of the cloning

efficiencies of floating cells, loosely attached cells and
firmly adherent cells of an anchorage independent cell line
(AU-471} was done.
Media was decanted from culture flasks and constituted
the "floater" fraction.

The flasks were gently washed once

with PBS, then 20 ml of PBS was added and the flasks shaken
to obtain loosely attached cells.

The flasks were washed

again with PBS and the remaining cells harvested (T/E).
Cell number and viability were determined for each fraction.
Four cultures of each of the three AU-471 fractions were
plated in soft agar at both 2 x 103

v.

and 2 x 104

v.

cells

per culture.
The number and viability of "floaters", loosely
attached and firmly attached LT-2 cells were also
determined.

Since LT-2 had been shown not to clone in soft

agar in over 1000 cultures, and since the floater and
loosely attached fraction represented a minor fraction of
dead cells they were not plated in soft agar (see Results}.
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F.

NUDE MOUSE GROW1'H
1.

GROWTH OF TUMOR CELL SUSPENSIONS IN NUDE MICE

Four nude (nu/nu) mice were kindly provided by Doctor
oonald Rowley, LaRabida Children's Hospital, Chicago, IL,
and 18 additional nude mice were obtained from Northwestern
university Animal Care Facilities, Chicago, IL.

The mice

were maintained in sterilized filter top cages in a laminar
flow hood.

All food, H20 and bedding were sterilized, and

the water was adjusted to a pH of 2.5 with HCl.

Two mice

were injected subcutaneously (s.c.) with 4 x 106 viable
LT-2 cells in 0.1 ml PBS into the upper dorsal thoracic
area.

(Pooled passages 21, 22, 23, 24, 26 and 27 with

viability of 89-95%).

Four mice received 8 x 106 LT-2 cells

s.c. (pooled passages 91% V.) and four animals received 10 x
106 viable LT-2 (Pas. pooled 26-29, 81-100% V.). Ten
animals were injected intravenously with LT-2 via the dorsal
tail vein; three with 5 x 106 viable cells in 0.1 ml PBS
and three with 1 x 106 cells (Pas. pooled 21-27, 89-95%
V.), and four additional animals received 1 x 106 viable
LT-2 in 0.05 ml intravenously (Pas. 22, 95-99% V.).

1wo

additional animals were injected with 2 x 106 viable AU-471
cells in 0.05 ml PBS intravenously (Pas. 119, 79% V.).
Subcutaneously injected cells that resulted in nodule
formation were harvested at 3 months, 4-1/2 and 7 months.
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Nodules were cut into four small pieces.

One portion was

frozen in O.C.T., one was fixed in paraformaldehyde, and
one portion was fixed in formalin and imbedded in parafin
blocks, cut and stained with hematoxalin and eosin.

The

last piece was chopped into small fragments and placed in
culture.
2.

INTRAVENOUS INJECTED NUDE MICE

One animal convulsed apparently suffering a pulmonary
embolus from injection of tumor cells.

The remaining

animals (twelve) survived and were sacrificed or died from
day 33 to day 200

post-injecti~n.

The animals were

autopsied, and no tumor tissue was noted in the peritoneal
or pleural cavity.

Lungs, spleen and livers were fixed in

formalin and processed for hematoxylin and eosin staining.
3.

NUDE MOUSE CULTURES

Nude mouse nodules were maintained in culture as noted
above until partial confluent flasks were obtained.

Two

nude mouse nodule cultures (NMNC) were successfully
propagated in tissue cultures.

Nude mouse nodule cells and

nude mouse skin fibroblasts were karyotyped using the
procedure described above.

The two successfully propagated

nude mouse nodule· cultures (NMNC) were later cultured in
soft agar to determine if successful passage through nude
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mice would alter their anchorage independent culture
properties.
4.

SOFT AGAR
CULTURE

EXPcHIME~TS

WITH NUDE MOUSE NODULES IN

Five 60 mm culture plates were seeded with 1 x 105
viable (58% V.) LT-2, (NMNC culture No. 5) in soft agar,
and five additional cultures with 1 x 105 viable LT-2
overlaid with agar (controls).

Another soft agar

experiment compared NMNC No. 5 and NMNC No. 7.

Each were

cultured in five 60 mm culture plates with 1 x 105 viable
LT-2 cells per plate in soft agar.

There r,vere five

"preplate controls" with agar poured over the cells for
both NMNC 5 and 7.
5.

KARYOTYPE OF NUDE MOUSE CELLS

Cells from nude mouse nodules that were aJain
established in vi tr.o were karyotyped as describ\:d above.

CHAPTER IV
RESUL'rS
A.
1.

CELL CULTURES

GROWTH AND HISTOLOGY OF LT-2 IN TISSUE CULTURE
LT-2, a vulvar carcinoma cell line has been

successfully maintained in tissue culture for 4 years
through 50 passages, probably representing between 100-200
generations considering a plating efficiency estimated at
40% (Section 2: Plating Efficiency).

The plating

efficiency has improved during the four years of
observation.

Viability of freeze-thawed LT-2 cells was

generally good (average 87.1% V.).

This is the third

vulvar cancer established in tissue culture.

Cell

rnonolayers, grown on cover slips in Leighton tubes, and
also single cell suspensions evaluated by Papanicolaou
staining were both cytologically malignant.

Cells are

predominately mononuclear with multiple prominent nucleoli,
weakly basophilic cytoplasm, and a large nuclear/cytoplasm
ratio (Figure 1).

Both cells and nuclei are pleomorphic

with occasional giant forms.

Fre'quent mitoses are noted.

During the four years of observation, LT-2 has continued to
grow as a very strict monolayer with no piling up of cells
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Figure 1.
LT-2 monolayer from Leighton tube culture, fixed
in absolute ethanol. (Giemsa stain x 300.)
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as frequently noted in other tumor cells in tissue culture
(Figure 2).

Electron micrographs show both dense and

fibrous nucleoli and numerous mitochondria, rough
endoplasmic reticulum, light-staining vacuoles, and
tonofibrils characteristic of epithelial cells.
particles were noted.

No viral

Using aceto-orcein staining of

Leighton tube cover slip monolayers, no mycoplasma were
noted.
2.

PLATING EFFICIENCY

Following plating, LT-2 cells attached to the plastic
substrate of the culture flask and began to "spread".

One

difficulty in determining plating efficiency was that cells
continued to attach to the substratum over a period of time
after plating.

If cells were counted too early, before all

potential plating cells attached, an inaccurately low value
might be obtained.

Likewise, if plating efficiency was not

determined soon after plating, cell division might give an
inaccurately high value.

The use of both mitomycin C

treated cells and untreated cells helped determine a more
accurate plating efficiency.
No. cells harvested
No. cells plated

Plating efficiencies

x 100 varied between 11.3 and 36% at 2

hours and cell attachment leveled off between 2 and 4 hours.
Mitomycin C treated cells showed a 20.5% attachment
efficiency at 2 hours which leveled off to 40.6% by 4
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Figure 2.
Comparison of cell growth in vitro:
top, LT-2,
note the strict monolayer growth; bottom, AU-471, note the
piling up of cells.

90
hours.

No further increase in cell attachment to the sub-

stratum was noted after 4 hours.

By 12 hours, a considera-

ble variation in the number of cells harvested was noted between the mitomycin C treated and untreated cultures with
plating efficiency increasing to 61.8% in the untreated cultures indicating cell growth in culture.

These experiments

indicate an average plating efficiency for LT-2 of about
40% with cell attachment plateauing between 2 and 4 hours.
Cell division was noted shortly after plating (Figure 3).
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B.

TUMOR-HOST INTERACTIONS IN VITRO
1.

92

LYMPHOCYTES

Total white blood count (WBC) was consistently
elevated (10-30,000 WBC per mm3) during the 15 months of
observation, yet the total peripheral blood lymphocytes
(PBL) percentages and absolute numbers were depressed.
Total and active T-RFC percentages and absolute numbers were
also depressed.

An increase in PBL, total and active T-RFC

% and absolute numbers occurred following BCG immunization;

confirming a bone marrow sparing effect of this form of
therapy.

B-RFC percentages were also depressed below

normal levels, and also increased following BCG therapy.
All values returned to their previously repressed values
over a period of several months despite continued BCG
injections (Figure 4).
2.

CYTOTOXICITY

Chromium release cytotoxicity assays were done on two
occasions using patient and control lymphocytes versus
autologous tumor or an unrelated malignant cell line
(AT-264).

Cytotoxicity was assayed separately in autologous

and control plasma.
The first assay (Exp. 1) revealed no patient lymphocyte
cytotoxicity against her own tumor in autologous or in
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control plasma or against the lung carcinoma cell line
(AT-264).
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Control lymphocytes also showed no specific

cytotoxicity although some "spontaneous or natural"
cytotoxicity was noted against control target cells in both
control and patient (M.L.) plasma (9.12 & 10.07% LMC).
Control LMC against LT-2 cells was more varied showing only
0.63% cytotoxicity in patient plasmas and 11.73% LMC in
control plasma.

(Although no statistically significant

conclusions can be drawn from this variation because of the
large standard deviations of samples in control plasma).
The patient's "natural" cytotoxicity was depressed against
both her own autologous tumor and AT-264 cells in
autologous plasma, although some (4.70 ± 1.56% LMC)
spontaneous cytotoxicity was noted against AT-264 in
control plasma.
During the first and second cytotoxicity assays and
until the patient's death two months later her general
health and nutritional status continued to deteriorate.
All skin tests, including skin tests to autologous tumor
extracts, were negative at that time.

DNCB skin testing

was negative, and total PBL, T-RFC, active T-RFC and B-RFC
percentages and absolute numbers were depressed.

Yet,

despite her general state of anergy, and her considerable
tumor burden at that time, a significant degree of specific
cytotoxicity (P< 0.001) was noted in both autologous and
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control plasma (15.93 & 11.44% LMC, respectively)
her autologous tumor.

a~ainst

Also a small increase in "natural"

cytotoxicity (4.64 & 6.37% LMC) was noted against AT-264 in
both control and autologous serum.

Control lymphocytes

again showed the expected degree of "natural" cytotoxicity
(8.09 & 9.40% LMC) against AT-264 similar to the first
experiment.

Again no natural cytotoxicity was noted

against LT-2 using control lymphocytes, but a very large
variation in standard deviation in cytotoxicity was noted in
control plasma (S.D. ±22.38).
This increase in cytotoxicity with patient's
lymphocytes against her own tumor occurred 2 days following
several blood transfusions.

It is interesting to speculate

that this increase in cytotoxicity was an example of the
"allogenic effect" or a more remote possibility is that it
occurred because of immune reactivity of viable transfused
lymphoid cells.
The patient's sister's lymphocytes were also assayed
for cytotoxicity against LT-2 in control plasma and none
was noted.
3.

(Table 1.)
LYMPHOBLAST TRANSFORMATION

PHA induced blastogenesis was assayed on four
occasions and remained markedly depressed throughout the
perjod of observation.

No increased response was noted

TABLE 1
LYMPHOCYTE - MEDIATED CYTOTOXICITY:
Lymphocytes

Targets

% LMC

CHROMIUM RELEASE ASSAY

±

S.D.

No.

Plasma

3.00
2.09
1. 56
3.49
17.81
2.03
1. 22
1. 38

4
4
4
4
4
4
3
4

Control
M.L.
Control
M.L.
Control
M.L.
Control
M.L.

2.35
0.32
1. 66
1. 88
22.38
2.84
0.57
2.58
5.92

3
3
4
4
3
3
4
4
3

Control
M.L.
Control
M.L.
Control
M.L.
Control
M.L.
Control

Experiment 1
Control
Control
M.L.
M.L.
Control
Control
M.L.
M.L.

i

AT-264
AT-264
AT-264
AT-264
LT-2
LT-2
LT-2
LT-2

9.12
10.07
4.70
0
11.73
0.63
1. 79
0
Experiment 2

Control
Control
M.L.
M.L.
Control
Control
M.L.
M.L.
Sister

AT-264
AT-264
AT-264
AT-264
LT-2
LT-2
LT-2
LT-2
LT-2

8.09
9.40
4.64
6.37
0
0
15.39
11.44
0

1.0
(J'I
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despite the increase in PBL, T-RFC and active T-RFC
following BCG.

Also no increase in blastogenesis was noted

following blood transfusions similar to the increase in LMC
noted above.

Blast transformation to KCl extracts of LT-2

cells ( 1 .M-9 or 10 .M.9 protein) showed no antigenic
recognition by the patient, or by a close household contact
(the patient's sister), or by a non-tumor control patient's
lymphocytes.

No blast transformation was noted to KCL

extracts with mitomycin C treated patient, sister or control
lymphocytes (control for non-specific thymidine uptake) or
using a KCl extract of a normal human fibroblast cell line
(control for non-specific lymphocyte stimulation).
2.)

(Table
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TABLE 2
LYMPHOBLAST TRANSFORMATION
Stimulation
Index
Antigen
Lymphocytes
M.L.

Control

Sister

~

~ignificantly

± S.D.

PBS
PHA
PHA 1/10
LT-2 KC1 (10A.<g)
LT-2 KC1 ( 1_p.g)
LT-2 + me
LT-2 + me
(M. L. plasma)
LT-4 KC1

1. 00
6.8o*
14.39*
1.14
1.28
1.04
1. 36

0.15
1. 01
0.97
0.38
0.24
0.29
0.10

1.87

1. 01

PBS
PHA
PHA 1/10
LT-2 KC1 (lO.M.g)
LT-2 KCl ( 1_)Ag)
LT-2 + me
LT-2 + me
(M. L. plasma)
LT-4 KCl

1.00
67.06
74.52+
1.21
1. 08
1.05
1.12

0.07
22.49
12.49
0.18
0.25
0.10
0.24

1.05

0.14

PBS
PHA
PHA 1/10
LT-2 KCl (10 A.g)
LT-2 KCl ( 1~g)
LT-2 + me
LT-2 + me
(M. L. plasma)
LT-4 KCl

1. 00
56.15
93.74+
1.43
1.10
1.16
0.90

0.29
22.49
13.45
0.20
0.33
0.15
0.06

0.99

0.03

lower than PHA stimulation of control
lymphocytes (P < 0. 01)
+ Not significantly different from normal population
(S.I.=116±26; P)0.1)
PBS: 0.01 ml phosphate buffered saline
PHA: Phytohemagglutinin (Difco PHA-P), undiluted or
diluted 1:10 ·
LT-2 KCl: KCl extract or cultured LT-2 cells (l~g or
10 g protein in 0.1 ml PBS)
LT-2 +me: 104 mitomycin C - treated Lt-2 cells in 0.1 ml
PBS
LT-4 KCl: KCl extract of normal human fibroblasts (10~g
protein in 0.1 ml PBS)
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C.

TUMOR-HOST INTERACTION:
. 1.

IN VIVO

SKIN TESTS

Initially, the patient (M.L.) responded to only one of
the five recall bacterial skin test antigens
(dermatophytin-0).

She was anergic to all other skin test

antigens including PPD.

No response was noted to DNCB.

The patient received BCG intralesional immunotherapy (see
below), and was again skin tested.

At that time, she

responded to PPD, but was now anergic to dermatophytin-0.
Two months later, she was again re-tested, and she was then
totally anergic to all recall skin test antigens including
PPD despite the fact that she had received three BCG
immunizations and was previously PPD skin test positive.
Still no response was noted to DNCB.

She remained totally

anergic when again re-tested six weeks later.

The patient

was also anergic to skin testing with autologous KCl tumor
extracts.
2.

BCG

Following the first BCG intralesional immunization, the
patient became hyperthermic for 2 days.

No decrease in the

size of the right inguinal lesion was noted, and by the
time of the third ·intralesional injection the mass had
doubled in size (3 months).

No beneficial clinical response

was noted to BCG injections, aithough an increase in PBL's
occurred as noted above.
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D.

CELL CHARACTERIZATION AND TUMOR PROPERTIES
1.

ELECTRON MICROSCOPY

As pointed out by Bernhard, the ultrastructural
differences between normal and malignant cells are
quantitative rather than qualitative.

Well differentiated

cancer cells generally resemble the tissue of origin and
contain organelles characteristic of differentiation.
There is no universal ultrastructural pattern characteristic
of cancer (200). Electron micrographs of LT-2 revealed
numerous pinocytotic vacuole and lysosomes with prominent
tonofilaments.

The presence of tonofilaments is

characteristic of epithelial cells or undifferentiated tumor
cells (201).

No keratonyalin was noted.

appeared normal in numbers and appearance.
showed large prominent nucleoli.

Mitochondria
The nucleus

No virus particles were

noted.
2.

KARYOTYPING

Karyotyping of 38 cells revealed marked aneuploid
variation with chromosome numbers varying from 47 to 81
with no single modal number, although a tendency toward a
triploid hypertriploiu modal range was noted.

Abnormal

marker chromosomes and ring chromosomes were noted.
Karyotyping four years later still revealed aneuploidy with

101

marked variations in chromosome numbers.

(Table 3 and

Figure 5).

3.

GENERATION TIME

The doubling time was determined using the
relationship log N =

0

·~~lt + log

No and was calculated to

be 32 hours, during the initial log phase of growth from 27
to 72 hours in culture (Figure 6).

Pirt has noted that the

validity of such calculations are based on the assumption
of constant exponential growth as noted with procaryotes and
constant environment conditions (202).

Fractions of

non-growing cells resulting from cell differentiation,
production of inhibitors, etc., would invalidate the
assumption of exponential growth.

Cell generation time

calculated by time-lapse cinematography (see below) was
highly varied with one multinucleated cell dividing twice in
only 88.5 minutes (from one cell division to another) while
other cells did not divide at all.

4.

TIME-LAPSE CINEMATOGRAPHY

The doubling time of individual cells (cell cycle time)
was calculated by observing the interval between two
consecutive cell divisions and counting the number of frames
during that interval and dividing by the number of frames
per minute (2 frames per minute).

The interval between
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TABLE 3
FREQUENCY OF LT-2 CHROMOSOME
DISTRIBUTION OF 38 CELLS
Cells:
Chromosomes:

1
47

1
48

50

1
51

1
52

1
54

1
55- -

Cells:
Chromosomes:

1
56

1
57

1
58

1
60

1
62

2
63

1
64

Cells:
Chromosomes:

2
65

1
65

1
68

5
69

3
72

4
73

3
74

Cells:
Chromosomes:

1
75

1
78

1
81

2
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divisions was noted to vary considerably between cells with
some cells dividing twice while other cells within the same
colony did not divide at all.
Cell division did not necessarily appear to correlate
with cell size.

Some small cells were noted to divide while

much larger cells with abundant cytoplasm did not divide.
Also cell division did not necessarily occur with equal
division of the cytoplasm.

As noted above, the interval

between two cell divisions of one multinucleated cell was
only 88.5 minutes.

Some other cells within the same colony

did not divide at all during the period of observation about 4 days.

Considerable movement or membrane ruffling

was noted by many cells.

Individual cells were noted to

move in and out of the photographic field, and one small
colony consisting of about 10 cells was also noted to move
as a group, demonstrating a total lack of cell to cell
contact inhibition of cell movement-topoinhibition (Figure
7) •

Cell to cell adherence was demonstrated in one film.
As a cell moved away from a small colony, a long
cytoplasmic stream attached to an adjoining cell was "left
behind" pulling out the membrane of the stationary cell.
When the cells finally separated, both cells rapidly
recoiled in a fashion similar to a rubber band that had
been stretched out and then released - suggesting rather
firm cell to cell contact (Figure 8).
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Figure 7. Time lapse cinematography showing movement of a
whole colony. Cell a. moving away from colony.
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Figure 8.
Time lapse cinematography showing cell to cell
adhesion with cell b. moving away from colony.
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5.

SATURATION DENSITY

AU-471 reached confluent growth with a maximum saturation density of 10.4 x 105 cells/cm2 at 11 days in culture
(average 8.68 x 105 cells/cm2 with a range from 7.76 to
1.04 x 105 cells/cm2 from day 9-14).

LT-2 reached a maximum

saturation density of 1.20 x 105 cells/cm2 at 14 days in
culture (average of 1.10 cell/cm2 with a range from 1.02 to
1.20 x 105 cells/cm2 from day 10-16).

WI-38 reached a maxi-

mum saturation density of 0.074 x 105 cells/cm2 at day 29
in culture (average 0.0639 x 105 cells/cm2 with a range from
0.0522 to 0.074 x 105 cell/cm2 from day 15 to 35).

Even

after 35 days, WI-38 cultures were not totally confluent.
AU-471 which grew with "heaped-up" colonies reached a
maximum saturation density about 8.6 times higher than LT-2
and 140 times greater than WI-38.

Saturation density for

LT-2 was 16 times greater than WI-38.

Both LT-2 and WI-38

grow as a strict moholayer without "heaped-up" cells as
noted with AU-471, and both have a much lower saturation
density (Table 4).

TABLE 4
SATURATION DENSITY OF LT-2, AU-471 AND WI-38 CELLS IN VITRO
LT-2
-Saturation
Density
Tiiile In
Culture
No. cells/
cm2 x 105*
Days

AU-471

WI-38

Time In
Culture
Days

Saturation
Density
No. cells/
cm2 x 105*

Time In
Culture
Days

Saturation
Density
No. cells/
cm2 x 105*

10

1. 02

8

3.86

15

.0662

11

1. 09

9

7.76

17

.0552

14

1. 20

10

8.81

21

.0721

15

1.17

11

10.4

24

.0522

16

1. 06

14

7.66

29

.0741

15

5.22

32

.0652

35

.0622

* Average of three cultures

.....
0
\0
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6.

DENSITY DEPENDENT INHIBITION OF CELL DIVISION

·Review of stained Leighton tube cover slips of LT-2
revealed mitotic figures both in the center of large colonies with cell contact on all sides of dividing cells and
on the periphery of the colonies (Figure 9).

AU-471 also

demonstrate cell division throughout large colonies (Figure
10).

WI-38 did not form discrete colonies.

Instead,

cel~s

were noted to form anastomosing columns with individual
cells and small groups spread over the slide.

Fewer cell

divisions were noted compared to LT-2 or AU-471 cultures
and only rare cell divisions in the center of large colonies
were noted by cells compietely.surrounded and in contact on
all sides with other cells (Figure 11).
7.

SURFACE ANTIGENS: ABH

Agglutination of LT-2 was noted using anti-A.

Since

the patient (M.L) was known to be blood type A, this normal
cell marker has remained invariant in her tumor.

No agglu-

tination was noted with anti-Rho or anti-RhC (patient was
Rh positive, but the Rho antigen is generally expressed
only on red blood cells).

No agglutination occurred with

anti-B, anti-H substance or PBS.

LT-2 agglutinated in the

presence of normal rabbit serum.

Heterophile positive hu-

man serum (from a patient with infectious mononucleosis) did
not agglutinate LT-2, but did agglutinate SRBC's.

Normal
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Figure 9. Colonies of LT-2 demonstrating cell division (arrows) by cells in the center of a colony with cell contact
on all sides.
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Figure 10. Colonies of AU-471 demonstrating cell division
(arrows) by cells in the center of a colony with cell contact on all sides.

113

Figure 11. WI-38 with cell division (arrows) by cells
separated from other cells. Cell division was uncommon compared to LT-2 or AU-471 cultures. Only rare cell division
was noted by a cell in the center of a large colony.

1 14

human control serum did not agglutinate SRBC's or LT-2.
Infectious mononucleosis positive serum did not agglutinate
AU-471 nor was a heterophile-like antigen noted since no
agglutination with normal rabbit serum occurred (Table 5).
8.

FETAL ANTIGENS:

CEA, hCG

Spent media from cultured LT-2 cells concentrated 14.5
times as described in the section on Materials and Methods
was found to contain 21

ng~/ml

CEA per milliliter at pas-

sage No. 3, corresponding to 0.877 ng. per 106 cells per
day.

Fetal calf serum used in cell cultivation was also

found to contain CEA immunoactivity corresponding to 6.15
±0.83 ng. CEA per milliliter fetal calf serum or 0.922
±0.124 ng. CEA per milliliter complete medium or 13.4 ng.
CEA per milliliter of 14.5 times concentrated medium.

Thus,

in vitro production of CEA by LT-2 was significantly elevated above levels expected in concentrated complete media
with 15 percent fetal calf serum (P

< 0.001

).

CEA activity

attributable to LT-2 production decreased with continued
culture and was undetectable at passage No. 11.
dia was also found to contain 179 I.U.

~-hCG

Spent me-

per liter,

corresponding to an output of approximately 20 mi.U. (4
ng.) per 106 cells per day.

Immunoreactive hCG (cross-reac-

tive with LH) in this concentrated medium was found to be
only 9 I.U. per liter, at the lower level of sensitivity of

TABLE 5
DEMONSTRATION OF HETEROPHILE ANTIGEN ON LT-2
AND DIFFERENTIATION FROM INFECTIOUS MONONUCLEOSUS HETEROPHILE
ANTIGEN
Sheep RBC
*NRS

+

**Im+

+

LT-2

AU-471

Human Blood Type A RBC

+

+

***Im-

*NRS = Normal Rabbit Serum
**Im+

=

Infectious Mononucleosus Positive Antisera

***Im- - Infectious Mononucleosus Negative Antisera

V1
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the radioimmunossay, and did not increase when the medium
was concentrated (immunoreactive~-hCG did increase in the
medium with concentration), indicating prefecential secretion of the beta subunit of hCG by LT-2 cells.

9.

SERUM DEPENDENCE

LT-2 was plated at 5 x 104 cells per well in 10%, 1%,
0.1%, .01% and 0 serum and was harvested at 4 days, resulting in recovery of 4 x 104 cells from 10% serum, 2.3 x 104
cells from 1% and progressively fewer cells in less serum,
but some cells survived even when cultured in 0 serum (1.7
x 104 cells at 4 days).

Plating LT-2 in 15% serum and

changing to lower serum concentrations as noted above after
24 hours, did not consistently produce incceased growth.
In a repeat experiment, LT-2 was plated at higher concentrations (1.5 x 105 cells per well) and harvested later
(6 days).

High yields were noted with 10% and 1% serum

(2.5 and 3.6 x 105 cells per well), indicating growth in
10% and 1% serum, but lower cell yields were noted with
0.1, 0.01 and 0 serum (1.2, 0.8, 1.2 x 105 cells per well)
indicating cell survival in limited serum, but not growth.
These data indicate serum growth dependence by LT-2.

In

contrast, AU-471 dem~nstrated ser~m independence with growth
at both 10% and 0 serum, but much greater growth at the
higher serum levels (1.5 x 105 cells per well plated with
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yields of 20.5, 12.2, 5.1, 2.6, 2.6 in 10%, 1%, 0.1%, 0.01%
and 0 serum, respectively).

Plating in 15% serum for 24

hours prior to feeding with various serum concentrations resulted in much better growth in all cultures compared to
cultures initially plated in lower serum concentrations.
These data indicate serum independence but also response to
serum, suggesting retention of receptors for growth stimulating factors in serum by AU-471.

Interestingly, WI-38, a

"normal diploid" cell line also demonstrated serum independence when harvested at 4 days but with better growth when
plated in higher serum concentration.
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E.

GROWTH IN SOFT AGAR:

ANCHORAGE INDEPENDENT GROWTH

SOLUBLE STIMULANTS & INHIBITORS:
EXPERIMENTS, LT-2:AU-471

1.

CO-CULTIVATION

Preliminary studies revealed that LT-2 did not clone in
soft agar.

This lack of anchorage independent growth by

LT-2 was of particular interest since most turnors·in tissue
culture clone in soft agar (Figure 12). In fact, soft agar
anchorage independent growth is currently the most reliable
assay of in vitro malignancy.

Although Marshall has

reported a human malignant bladder carcinoma that did not
clone in soft agar, but was tumorogenic in the nude mouse
(203).

Smith and Temin had demonstrated that serum

independence by tumors results from production by the tumor
of growth stimulating factors that can replace serum (204).
The possibility that a soluble inhibitor or stimulant was
responsible for anchorage dependent or independent growth
was considered.

Experiments were done to determine whether

anchorage independence was a function of a soluble product
produced by cells capable of growth in soft agar and/or
whether non-cloning cells produced a soluble inhibitor.
Two co-cultivation experiments using untreated LT-2
cells cultured with AU-471 showed an increase in soft agar
plating efficiency of AU-471 when colonies were scored at
about two weeks.

One experiment showed a dose response
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Figure 12.

Clones of AU-471 growing in soft agar.
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increase (1:10>1:1) in plating efficiency (control mean
55.0 ±10.87; 77.3 ±11.69 co-cultured with 2 x 103 LT-2
giving an LT-2:AU-471 ratio of 1:1; and 129.2 ±26. 16 with 2
x 104 LT-2 giving an LT-2:AU-471 ratio of 1:10) (P<0.001).
After 24 days, no significant increase in cloning efficiency
was noted at the lower (1:1) feeder to response cell ratios,
but a significant (P<0.001) response was still noted at the
higher (1:10) cell ratios (Table 6.)

This gloss" of feeder

effect by 24 days in the 1:1 co-cultivation may have
resulted from the much greater increase in cloning
efficiencies occurring in control plates (3.32 x increase)
from day 14 to day 24 compared to test plates (2.52 x for
1:1 and 2.22 x for 1:10).

Similar results

were seen in

other experiments using AU-471 co-cultivated with mitomycin
AU-471 (see below).
Another experiment used low and high cell ratios of
responder and feeder cells.

{1 :5 and 1:50 AU-471 :LT-2

ratios with 2 x 103 "responder" AU-471 as above, but also
with 2 x 104 responder cells).

Significant (P<.001)

increases in cloning efficiency were noted when cultures
were scored at both 15 days and 26 days, and at both low
and high AU-471:LT-2 ratios and with low and high numbers of
responder AU-471 cell's {Table 7).· Plating efficiency of
control AU-471 was greater with 2 x 104 AU-471 (4.97%)
compared to 2 x 103 AU-471
effect.

(2.36%) suggesting a self-feeder

TABLE 6
ENHANCEMENT OF AU-47la GROWTH IN SOFT AGAR BY LT-2
LT-2d
No. X 103

No. of Colonies (Mean± S.D.)
pC
pC
Day 14
Day 21

± 10

0

55

2

77 : 11
129 :

20

26b

-

183

± 8

Increase In
Cloning Efficiency:

-

3.3

.001

195 :23

N.S.

2.5

.001

295 !3ob

.001

2.2

Da:t 21

Day 14

a = 2 x io3 AU-471, 75% viable
b

= Significant
p

<. 001

increased number of colonies compared to 2 x 103 LT-2 cultures,

c

=

P values compare significance to cultures with 0 LT-2 cells

d

=

No growth in LT-2 soft agar control cultures

_.

....

tv

TABLE 7
ENHANCEMENT OF AU-471 GROWTH IN SOFT AGAR BY BOTH
HIGH (1:50) AND LOW (1:5) AU-471:LT-2 CELL RATIOS
AU-471
No. X 103

LT-2a
No. X 103

2

0

2

100

154 ± 34

20

0

995 ±243

20

100

No. of Colonies (Mean! S.D.)
Day 15
pC
Day 26
pC
47

±

18

1000

129 ± 11
.001

256 ± 30

.001

1700 ±428
sig. 412ob±868

.001

a

~

No growth in LT-2 soft agar control cultures

b

=

Plating efficiency calculated after counting only a portion of the total plate

c

=

P values compare 100 x 103 LT-2 cultures to 0 LT-2 with comparable numbers of
Au-471

Sig.= Obviously significant, but could not be calculated

.....
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These experiments demonstrated stimulation of cloning
efficiency or growtn of an anchorage independent cell by an
anchorage dependent cell rather than inhibition which was
expected. The response is dose dependent and more evident
when cultures are scored early (2 weeks) rather than late
( 3-4 weeks) .

2.

SOLUBLE STIMULANTS & INHIBITORS:
MITOMYCIN C TREATED LT-2:AU-471

CO-CULTIVATION,

Three additional experiments used increasing
concentrations of mitomycin C "feeder" LT-2 cells.
Mitomycin "feeder" cells were used to insure that the
increased cloning noted by AU-471 in previous experiments
was not the result of clone formation by LT-2.

One

experiment confirmed a significant (P< .05- .01) "feeder
effect" with cloning efficiency increasing directly with
increasing numbers of feeder cells at day 18 (Table 8).

No

difference between test and control cultures was noted by
day 24 except for one set of cultures with 1 x 104 feeder
cells (P< 0.05).

In another experiment no dfeeder effect"

was noted at either 15 or 22 days, but the cloning
efficiency of control plates was 25% by 15 days and 64% by
22 days.

This cloning efficiency of controls in this

experiment was much higher than noted in other experiments
in which "feeder effect" was clearly demonstrated {Table 9).

TABLE 8
DOSE DEPENDENT ENHANCEMENT OF AU-471 CLONING EFFICIENCY WITH VARIATIONS
IN MITOMYCIN C TREATED LT-2 CELLS

No.

LT-2
X 104

b

No. of Colonies Mean± S.D.)
pC
pC
Day 14

0

51

± 6

-

1

49

± 7

N.S.

62

±

9

N.S.

2

59

± 4

• 05

61

±

6

N.S .

63

±

9

.05

76

±

16

N.S.

10

77

±

9

.01

92

±

6

.05

50

74

±

6

.01

83

±

5

N.S.

5

a

Day 18

.

74 ± 15

= 500 AU-471 per culture, 5 cultures per group
= No growth of LT-2 soft agar control cultures

c = P values compare significance to cultures with 0 LT-2 cells
~

"'

ol:ll-

TABLE 9
LACK OF LT-2 FEEDER EFFECT ON AU-471 CLONING EFFICIENCY
IN SOFT AGAR CULTURES WITH HIGH SPONTANEOUS CLONING EFFICIENCYa

No.

LT-2C
X 103

No. Colonies
Day 15

(Mean~ S.D.)b
Day 22

0

505

±

41

1239

±

214

1

506

±

49

1267

±

295

2

524

28

1212

498

25

1226

10

550

30

1232

±
±
±

102

5

±
±
±

a

= No

b

~

Cloning efficiency 25%

c

=

No growth in LT-2 soft agar control cultures

197
163

significant differences noted between co-cultured and control cultures
cloning efficiency

""
U1
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The last experiment showed no "feeder effect" (Table 10).
rn fact, inhibition of soft agar cloning efficiency was
noted with 5 and 10 x 105 feeder LT-2 cells.

This experi-

ment had a very low viability of mitomycin C treated LT-2
feeder cells (35%) which may have accounted for the inhibition (Table 10).

These experiments using mitomycin C

treated LT-2 demonstrated "feeder effect", but generally
only when colonies were scored early (usually 2 weeks) in
the experiment and when the cloning efficiency of control
cultures was low (generally less than 20%). The last experiment suggested that large numbers of dead mitomycin C
treated feeder cells might decrease cloning efficiency.
3.

SOLUBLE STIMULANTS & INHIBITORS:
AU-471 FEEDING AU-471

CO-CULTIVATION,

Experiments were done to determine whether AU-471
could stimulate its own cloning efficiency in soft agar using mitomycin AU-471 "feeder cells".

In two co-cultivation

experiments using mitomycin C treated AU-471 cells as feeder
cells and untreated AU-471 responder cells, a significant
increase (P<.05- 0.01) in AU-471 soft agar cloning efficiency was noted when cultures were scored at about two
weeks, and the efficiency increased directly with the number
of feeder cells (Table 11 and Table 12).

Evaluation of

cloning efficiency at 4 weeks was more variable with one ex-

TABLE 10
INHIBITORY EFFECT OF HIGH NUMBERS OF CO-CULTIVATED LT-2 CELLS
ON THE CLONING EFFICIENCY OF AU-471
LT-2b
No. X 103

Day 17

No. of Colonies (Mean~ S.D.)
pC
Day 25

10

315

20

276

± 39
± 23
± 37

50

242

±

100

80

0

297a

-

473

N.S.

494

N.S.

34

:!: 29

pC

N.S.

427

± 48
± 59
± 45

.05

360

:!: 16

.05

.005

110

:!: 26

.005

a

~

Cloning efficiency 15%

b

~

No growth in LT-2 soft agar control cultures

c

=

P values compare significance to cultures with 0 LT-2 cells

N.S.

.....
N
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TABLE 11
DOSE RESPONSE INCREASED CLONING EFFICIENCY OF AU-471 CO-CULTURED
WITH MITOMYCIN C TREATED AU-471a
AU-471
No. Cells x 103

a

No. of Colonies (Mean± S.D.)
Day 14
pb
Day 23
pb

0

46 ± 6

<. 01

128 ± 12

N.S.

2

72 ± 8

(;01

130 ± 13

N.S.

5

88 ± 9

<· 01

143 ± 17

N.S.

10

92 ± 3

<.01

182 ± 10

<. 01

50

87 ± 7

<.01

210 ± 40

<.01

100

104 ±12

<· 01

181 ± 20

<. 01

=

500 viable AU-471 per culture, 89% viable

b • significant increased number of colonies compared to 0 LT-2, P(.Ol

1\,)
(X)

TABLE 12
DOSE RESPONSE INCREASED CLONING EFFICIENCY OF AU-471 CO-CULTURED
WITH HIGH NUMBERS OF MITOMYCIN C TREATED AU-47la
AU-47lb
No. Cells x 103
0

No. of Colonies
pC
Day 16
339

±

51

-

(Mean-+ S.D.)
Day 28
612

±

pc

44

10

398 ± 58

N.S.

608 ± 61

N.S.

20

430 ± 37

.01

592 ± 41

N.S.

50

474 ±1os

.05

622 ±135

N.S.

100

564 ± 57

.01

660 ± 53

N.S.

500

624

.01

668 ± 49

N.S.

±

37

a

~

2000 viable Au-471 per culture, 87% viable

b

~

72% viable, no colony formation in control mitomycin C treated cultures

c

=P

values compare significance to cultures with 0 mitomycin C treated AU-471
cultures

...

tv
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periment showing no signif'icant difference between feeder
cultures and controls, and the other experiment showing significant differences (P>O.Ol) only with higher numbers of
feeder cells (10, 50 and 100 x 103 feeder cells), but not at
lower feeder cell proportions (2 and 5 x 103 feeder cells).
similar results were noted (see above) in some LT-2:AU-471
feeder experiments suggesting that the "feeder effect" increases cell cloning efficiency early in experiments resulting in more recognizable (scorable) clones, but when
cultures are scored later (3-4 weeks) non-feeder cultures
had a greater proportional increase in cloning efficiency
often eliminating any noticeable "feeder effect" on cloning
efficiency.
~ile

Control cultures (Table 12) increased by 1.8 x

"feeder cultures" demonstrated a small increase in the

number of scorable colonies (l.Sx, 1.1x 1.4x 1.2x, 1.1).

4.

SOLUBLE STIMULANTS & INHIBITORS: CO-CULTIVATION,
WI-38:AU-471

Experiments were done using a "normal" near diploid
cell strain that does not clone in soft agar as "feeder"
cells to determine if cloning stimulating efficiency was
specific for tumor lines or was also produced by "normal
cells".

Co-cultivation of WI-38 with AU-471 also demon-

strated a "feeder effect" with significantly increased colony formation at both 14 and 22 days with AU-471J WI-38

13 1

cell ratios of 1:10 and 1:50 (P<.OOOS) (Table 13).

No colo-

nies were noted with 2 or 100 x 103 WI-38 cells plated alone
in soft agar (controls).

Cloning efficiencies of control

cultures were 1.6% at 14 days and 6.39% at 22 days indicating a 3.97 x increase while feeder cultures nad only a 3.50
x and 1.76 x increase.
A larger increase in cloning efficiency occurred in the
control cultures between day 14 and 22 than in "feeder" cultures with the smallest percent increase occurring in the
group with the highest number of feeder cells.

Similar re-

sults were seen in other experiments and suggest "self
feeding" with increased time in culture of control plates
with resulting stimulation of growth of controls later in
experiments (after 2 weeks).

Similar results were noted in

previous experiments (see above).
5.

SOLUBLE STIMULANTS & INHIBITORS:
CO-CULTIVATION,
LT-2 WITH MITOMYCIN C TREATED AU-471

No significant stimulation of soft agar growth by soluble products from AU-471 was noted in co-cultivation experiments using mitomycin C treated AU-471 to "feed" untreated
LT-2 (Table 14).

""

TABLE 13
ENHANCEMENT OF AU-471a CLONING EFFICIENCY BY CO-CULTIVATION
· WITH A "NORMAL DIPLOID" CELL LINE WI-38

WI-38
No. X 104

No. of ~olonies (Mean ±S.D.)
Day 14
pb
Day 21
pb

-

128 ± 30

-

INCREASE IN CLONING
EFFICIENCY:
Day 22
Day 14

0

32 ± 9

2

68 ±1o

.0005

239 ± 20

.0005

3.50

10

230 ±2o

.0005

405 ± 14

.0005

1. 76

3.97

a ~ 2 x 103 viable AU-471, 84% viable
b = P value compares significance with cultures with 0 WI-38 cells

w
N

TABLE 14
LACK OF ANCHORAGE INDEPENDENT GROWTH STIMULATION
OF CO-CULTIVATION WITH MITOMYCIN C TREATMENT
LT-2
No. X 103

AU-471
No. X 103

0

100

0

20

100

0

20

0

100

100

20

20

Results:

No colony formation in all cultures on day
14 or day 21

...w

w
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6.

MITOMYCIN C TREATED AND UNTREATED LYSED CELLS

Since mitomycin was being used to treat "feeder" cells,
an experiment was designed to evaluate mitomycin C in intact and lysed cells and when feeder and responder cells
were in "close contact" following centrifugation and incubation.
Control AU-471

(no co-cultivation with LT-2) had a

cloning efficiency in soft agar of 1.6% at 20 days (Table
15).

Feeder cultures with 1:1 untreated LT-2:AU-471 showed

no significant stimulation or suppression of cloning.
Feeder cultures with 105 untreated LT-2 (1 :50 ratio) resulted in total inhibition of AU-471 anchorage independent
growth.

Gross speckling of culture plates was noted as the

agar dried which microscopically represented lysed and dead
cells, cell debris and a few 2 and 3 cell clusters (probably of LT-2 origin), but no colonies.

Similarly, centrifu-

gation of LT-2:AU-471 with incubation for 60 min. at 37°C
(cell contact) resulted in no significant change at 1:1 ratios, but total inhibition of AU-471 cloning at 1:50 (105
LT-2) ratios.

Significant suppression was noted with 105,

but not 103 lysed LT-2 cells at 20 days.
Comparable mitomycin C treated LT-2 cells showed significant depression (P<O.OS) of AU-471 co-cultured with 105
~-2,

but no

oth~r

demonstrated suppression or stimulation

of colony formation by day 20.

.""''
TABLE 15
EVALUATION OF LT-2:AU-471 CELL CONTACT CELL LYSIS AND MITOMYCIN C
ON THE CLONING EFFICIENCY OF AU-471d
Experiment No. 1

No. of LT-2

Description
Control

32 ± 6

164 ± 32

Co-Culture

30 ± 4

143 ± 32

Cell Contact

30 .± 5

158

Lysed

23 ± 6

128 ±

0
103

b

~Significant

11
6a

6
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4

141

±
±

sa
3a

41 ± 7

132 ± 7a

oa

20 ± 2a

117 ± sa,b

Cell Contact

oa

oa

30 ±1o

183 ± 12b

45 ±14

158 ± 19C

11 ± 4a

8 ± la,c

suppression of cloning efficiency of AU-471 compared to control
cultures, P (.Ol
difference between groups labeled "b" P (.01

c ; Significant difference between groups labeled "c", P (.005
d

37

±
±

oa

Lysed

= Significant

±

25

Co-Culture

105

a

Mitomycin C Treatment of LT-2
Colony Count (Mean- S.D.)
me+
meDay 30
Day 20
Day 30
Day 20

=

2 x 103 viable AU-471

w

VI
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Mitomycin C treated and

~ysed

LT-2 showed significant

suppression with 103 but not 103 LT-2 at 30 days.

Findings

were similar at 30 days with suppression of AU-471 soft agar
cloning efficiency with 103 co-cultured, and cell contact
LT-2, but in addition, 10S co-cultured LT-2 cells showed
suppression (P<0.001) at 30 days.

No suppression.was noted

with 10S cell contact or lysed LT-2 groups at 30 days.
Significant suppression was noted in C all mitomycin C
treated groups except in 10S lysed and cell contact groups
at 30 days.
Comparison between mitomycin C and non-treated groups
revealed significant suppression between the 10S lysed groups at 30 days, and between 10S co-cultured and cell contact
groups at 30 days. This experiment indicates suppression of
AU-471 soft agar cloning with high numbers of untreated and
co-cultivated LT-2 cells at both 20 and 30 days, but not
with low numbers of untreated LT-2 cells.
cells also inhibited AU-471 cloning.

Untreated lysed

No feeder effect was

noted in this experiment with either mitomycin C or untreated cells.
A repeat experiment (Table 16) identical to the above
was done except 1 x 104 and 1 x 10S mitomycin C treated and
Untreated LT-2 were used instead of 1 X 103 and 1 X 10S and
colonies were scored at 2 and 4 weeks.

The ~ncrease to 104

instead of 103 LT-2 was used to maximize the possibility of

.....

TABLE 16
EVALUATION OF LT-2:AU-471 CELL CONTACT, CELL LYSIS AND MITOMYCIN C
ON THE CLONING EFFICIENCY OF AU-471
Experiment No. 2

No. of LT-2

Mitomycin C Treatment of LT-2
Colony Count (Mean± S.D.}
meme+
Day 14
Day 27
Day 15
Day 27

Description

0

10 ± 3

Control

104

± 8

Co-Culture

31

z

3b,c,g 302 ±64b

7

± 2C

33 ± 16

Cell Contact

29

±

3b,d,h 254 ±15b,e,j 11

± 3d

60 ± 23e

Lysed
105

39

6 ± 1g,h

60 ±18j

5

± 2

Co-Culture

oa

oa

14 ± 3

Cell Contact

oa

oa

33 ±1o

Lysed

8 -:!: 3

41 :!:

7

13 ± 3

50 ± 24
98 ±

9a

165 ± 2lb,f
71 ±

9b,f

a ; Total suppression of AU-471 cloning efficiency compared to control
b

= Significant

c

= c,d,e,f,g,h.j.:

enhancement of AU-471 cloning efficiency compared to controls, P(.01
Significant difference between groups with the same letter P(.01

~
~
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"feeder effect", since other

~xperiments

generally noted a

greater "feeder" when larger numbers of feeder cells (up to
1 x 10S) were used.

In this experiment AU-471 cloning effi-

ciency was 0.49% at 14 days and 1.9% at 27 days (much lower
than generally noted). A marked feeder effect was noted in
the 10 4 non-mitomycin C treated co-cultured and contact
groups (P<0.002), and a total suppressive effect with 10S
co-cultured or cell contact groups at both 14 and 27 day.
Lysed cells produced no suppressive effect in any group at
day 14 or 27.

No significant effects, suppressive or

stimulatory were noted with mitomycin C treated cells at
day 14. The mitomycin C treated groups showed "feeder effect" with 10S LT-2 in all three groups - co-cultured, contact and lysed at 27 days, but no significant difference in
all three groups with only 104 LT-2 at 27 days.

Comparisons

between mitomycin C and untreated and unlysed groups revealed stimulation by non-mitomycin C treated LT-2 compared
to mitomycin C treatment with 104 LT-2 at both 14 and 27
days, and marked suppression with 10S non-mitomycin C
treated LT-2 at both 14 and 27 days. No difference between
mitomycin C treated and non-treated lysed cells was noted.
These experiments indicate a complex series of growth
stimulation and inhibition that is dependent on both feeder
cell number, duration of cells in culture and treatment
with mitomycin

c.

In both experiments 105 untreated non-
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lysed LT-2 suppressed cloning of AU-471.

No effect was

noted with 103 LT-2 and a feeder effect (increase in cloning
efficiency) was noted with 104 LT-2~

Similar results have

been suggested in other experiments.

Low numbers of LT-2

cells generally have no effect "feeder" or inhibitory, but
stimulation occurs with higher numbers of cells and finally
inhibition occurs with large numbers of feeder cells.

Sup-

pression with large numbers of cells might result from competition for nutrients, direct toxic effect was suggested in
the first experiment using untreated lysed LT-2 cells, and
was not noted with 10S mitomycin C lysed cells (Table 15).
Direct toxic effect was also not confirmed in the second experiment with either untreated or mitomycin C treated lysed
cells.

Nutrient competition might explain the marked sup-

pression in cloning with 10S untreated LT-2 cells in both
experiments, but this "competition" is eliminated by mitomycin C treatment.
7.

CONDITIONED MEDIA

The effect of conditioned media rather than intact
cells or lysed cells was evaluated.

A cloning efficiency

of 3.8% (32 colonies) was noted at 17 days and a final efficiency of 5.9% (59 colonies) by 28 days (Table 17).

No in-

crease was noted in cloning efficiency with 15 or 30% conditioned or spent media (SM) from AU-471, but a significant

TABLE 17
DOSE DEPENDENT TRANSFER OF INCREASED CLONING
EFFICIENCY BY CONDITIONED MEDIA FROM LT-2 AND M.s.a
Source of
Conditioned
Media

Colony Count (Mean +
- S.D.)
p
Day 17
Day 28

p

-

59

±

7

6

N.S.

55

±

12

N.S.

±

4

N.S.

53

±

9

N.S.

74

±

11

.001

101

±

14

.001

15

51

±

11

.02

71

±

15

. N. S.

M.S.

30

81

±

14

.001

77

±

47

N.S.

M.S.

15

70

±

8

.001

100

±

18

.005

0

32

±

10

AU-471

30

31

±

AU-471

15

26

LT-.2

30

LT-2

0

a

Percent
Conditioned
Media

= Good

growth and viability of AU-471 control cultures on the bottom of culture
plates with 30% conditioned media from all three cell lines and overlaid with
soft agar

....

.c.
0
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increase (P<0.001) was noted with 30% LT-2 SM at both 17
and 28 days.

A significant increase was also noted with 15%

LT-2 SM (P<0.02) at 17 days, but not by 28 days.

A signifi-

cant increase (P<.001) was also noted with both 15 and 30%
SM from M.S. at 17 days, but only with the 15% SM by day 28.
Good growth and colony formation was noted in all preplated
controls showing cell viability and growth capabilities or a
substratum.
This experiment indicates that "feeder effect" can be
obtained with spent media from LT-2 or M.S.

Feeder effect

was more apparent when cultures were scored early rather
than later as noted in co-cultivation experiments, and a
dose response increase was noted with LT-2 conditioned media
at both day 17 and day 28.
8.

No inhibitory effect was noted.

SUMMARY OF AGAR FEEDER EXPERIMENTS

Stimulation of anchorage independent soft agar growth
in co-cultivation experiments was noted with a variety of
cell types both benign and malignant- AU-471, LT-2, WI-38
and M-S.

Co-cultivation stimulation could generally be

noted by two weeks, but results by 4 weeks were more varied
suggesting that the "feeder effect" stimulated growth
early, but that un-fed cultures eventually caught up, perhaps by conditioning their own media or production of
growth stimulant factors.· Control cultures generally demon-
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strated a greater proportional increase in cloning efficiency between early {2 weeks) and late {3-4 weeks) readings.

"Feeder effect" was not noted when control culture

showed high cloning efficiencies {>23%) by two weeks.

Ef-

fects of very low {2000 cells) numbers of co-cultivated
cells showed no "feeder effect".

High concentrat-ions of LT-

2 cells sometimes produced decreased cloning efficiency.
Feeder effect was most consistently noted with
10,000-50,000 feeder cells.

Mitomycin C treated and lysed

LT-2 cells were generally not inhibitory, but high numbers
of untreated lysed LT-2 cells were inhibitory. Mitomycin C
treated LT-2 cells were less effective as feeders and generally did not suppress.
9.

LT-2 CELL PROLIFERATION IN SOFT AGAR AND THE EFFECTS OF CYTOCHALASIN B

Four experiments were done to evaluate the number of
cells in soft agar versus time in culture and the effects
of cytochalasin B {an inhibitor of all movement).

The pe-

riod of observation was generally two to three weeks.
Counts of the numbers of cells per 150x microscopic field
for each of five fields in {generally) five plates were recorded on day one of.each experiment and repeat counts were
recorded at approximately weekly intervals.

The initial

experiment compared untreated LT-2 cells with mitomycin C
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treated LT-2 cells (Table 18) .•

A significant increase in

the number of cells per field (16.5 on day one to 26.1 by

day 23 was noted (P<0.0001), but no increase in mitomycin C
treated LT-2 controls.
A preliminary experiment suggested cytochalasin B
agar~

treated LT-2 cells also proliferated in soft
colonies consisting of aggregates of 8 -

Micro-

12 cells were also

noted, but cannot be attributed to the effect of cytochalasin B since similar microcolonies were noted in control untreated LT-2 plates and had on occasion been noted in other
LT-2 soft agar experiments.

Another experiment confirmed

LT-2 proliferation (P<0.0001) in the presence of cytochalasin B, but no colony formation was noted {Table 19).
proliferation of untreated LT-2 was noted.

No

Pre-plated con-

trol cells were noted to be healthy and proliferating on day
1 and day 14.
A final experiment, compared untreated, mitomycin C
treated, and cytochalasin B treated LT-2, and showed a significant increase in the number of cells per Hpf between day
1 and day 8 or 18 in untreated and cytochalasin B treated
LT-2 cells {P<0.0001), but no increase in the number of mitomycin C treated {control) cells (Table 20).
in cell number occurred early in

.the

The increase

experiment (between

day 1 and day 8) since no further increase was noted between day 8 and day 18.

TABLE 18
TIME-INDEPENDENT INCREASE IN THE NUMBER OF DISCRETE LT-2 CELLS
IN SOFT AGAR CULTURES WITHOUT COLONY FORMATION
LT-2
Treatment

0
100 _.u.g + mc/ml

a

Day 1

Cell Countsa
Day 8
Day 23

pb

17

21

26

.0001

19

19

19

N.S.

= Mean

count of number of cells per 5 high power microscopic fields from 5
plates (25 values)

b = Analysis of variance by Waller-Duncan K-ratio T test

...
~
~

,...,..

TABLE 19
EFFECT OF CYTOCHALASIN B ON THE GROWTH OF LT-2 CELLS IN SOFT AGAR
Treatment
of LT-2

Day 1

Cell Countsa
Day 7
Day 16

pb

Experiment 1
CB/ml

5 .AA3

20

26

30

.0001

Experiment 2
l...lAg

CB/ml

56

70

89

.0001

5 ,.u.g

CB/ml

50

75

91

.0001

54

50

51

N.S.

0

a

= Mean

b

= Analysis

count of number of cells per 5 high powered microscopic field from 5
plates (25 values)
of variance by Waller-Duncan K-ratio T test

= Cytochalasin B
N.S. = Not significant

CB

....
~

V1

TABLE 20
EFFECT OF CYTOCHALASIN B AND MITOMYCIN C ON THE GROWTH OF
LT-2 CELLS IN SOFT AGAR
Treatment
of LT-2

Day 1

0
1~

CB/ml

100 ,.,v.g + mc/ml

Cell Counta
Day 8

Day 18

pb

38

61

55

.0001

44

64

60

.0001

44

44

43

N.S.

a = Mean count of number of cells per 5 high powered fields from 5 plates (25 values)
b

= Analysis

of variance by Waller-Duncan K-ratio T test

CB = Cytochalasin B
+me
N.S.

= Mitomycin
= Not

C

significant

......
0'1
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In summary, these

experi~ents

indicate that LT-2 may in

fact divide early in soft agar, although only a 68.2% to
73.0% increase in total cell number was noted.

This small

increase in cell number may only represent cell division of
LT-2 cells already committed to cell division prior to
plating in soft agar.

Cytochalasin B did not inhibit this

cell division, but approximately the same per cent increase
in cell number was noted (67.1, 63.1, 55.1%).
were noted with cytochalasin B
10.

SOLUBLE PRODUCTS:

No colonies

treatment.

PROTEIN EXTRACT FROM AU-471

Experiments were done to evaluate protein extracts of
AU-471 on soft agar cloning of LT-2.
No LT-2 soft agar colonies were noted when cultured
with 20, 310 and 1000- g per culture of KC1 protein extracts from AU-471 with and without FCS.

Preplate controls

showed good viability with an estimated 75% of cells attached to the surface with 50% of cells spreading on the
substratum.

A few small 4-6 cell colonies were noted indi-

eating cell growth in the FCS(+) plates.

Preplates without

FCS(-) showed good viability and attachment, and only 10%
of cells flattened out on the surface.

.

No toxic effect was

noted from the AU-471 protein extract, but no soft agar
colonies were noted.
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11.

CELL CLUMPS IN SOFT AGAR

Attempts were made to determine if small aggregates of
LT-2 cells, could proliferate in agar using the cell clump
as a point of anchorage.

The possibility that a small ag-

gregate of cells might "condition" the media in the local
microenvironment of the clump was also considered.
Review of serial photographs of small clumps of cells
in soft agar showed no change in size indicating any additional significant growth in soft agar when plated in cell
clumps (see Figure 13, 14, and 15.).
12.

ENZYME TREATMENT:

CARBOHYDRASES, NEURAMINIDASE

Many cell functions are controlled by membrane glycoproteins.

Enzyme treatments were used to alter the membrane

surface glycoproteins.

Experiments were done to determine

the effect of such enzyme treatments on anchorage independent growth.
Preplate controls overlaid with agar showed some colony formation indicating cell viability and growth capabilities following enzyme treatment.

Light "speckling"

consisting of microcolonies generally in the range of 10-15
cells per colony were noted in control untreated plates and
also in treated plates.
10-15 cells were noted in
Sp~ckling

A few microcolonies consisting of
both~

andj3 glucosidase plates.

was frequently noted even in untreated culture
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Figure 13. Cell clump of LT-2 plated in soft agar and serially photographed. Top Day 1; Middle Day 7; Bottom Day
14.

15 0

Figure 14. Cell clump of LT-2 plated in soft agar and serially photographed. Top Day 1; Middle Day 7; Bottom Day
14 •

15 1

Figure 15. Cell clump of LT-2 plated in soft agar and serially photographed. Top Day 1; Middle Day 7; Bottom Day
14 •

r
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plates after 4 weeks when seeded with 105 LT-2 cells.

This

speckling generally consisted of dead cells and cell debris
noted when the agar began to dry, making interpretation
difficult.

The microcolonies noted did not appear to cons-

ist of healthy or viable cells.
No anchorage independent colony formation was noted
following incubation and plating of LT-2 with neuraminidase.

No definite conclusions can be drawn from these ex-

periments since several possible explanations exist including the possibility that important membrane glycoproteins
receptors are important in anchorage independent growth,
but are buried in the cell membrane or some manner protected
from the actions of the enzymes used.
13.

EFFECTS OF cGMP AND HEPES BUFFER

No anchorage independent growth of LT-2 was noted in
separate experiments using cGMP or Hepes buffer.
14.

EFFECTS OF AGAROSE AND/OR DEAE

No colonies (25 cells/colony) were noted with LT-2
cells plated in agarose or with DEAE.

Small clusters (mi-

crocolonies) consisting of 5-15 cells were noted in both
test and control plates of agarose and DEAE experiments,
and no enhancement of anchorage independent growth could be
attributed to elimination of negatively charged ions.

The
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presence of some "microcolonies" was frequently noted where
LT-2 was plated in high concentration.

(1 x 105 cells per

60 min. soft agar plate.)
Agar contains contaminating negatively charged ions
which might inhibit anchorage independent growth.

Increased

cloning efficiency has been reported using agarose (205).
No effect was noted using agarose.
ing the chelating agent DEAE.

No clones were noted us-

Heparin (negatively charged

molecule) has been reported to decrease cloning efficiency
in soft agar (206).
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F.

FIBRONECTIN
Fibronectin has been noted to restore normal cellular

behavior and morphology of in vitro tumors.

Experiments

were designed to evaluate the effect of fibronectin on
anchorage independent growth (Table 21).

Fibronectin

significantly increased (P<0.01) the cloning efficiency of
AU-471 in soft agar.

A more pronounced effect was noted

when cultures were scored early in

~xperiments

(2, 5, 6, and

7 fold increases) compared to later (0, 1.9, 2 and 3.1 fold
increases).
Increased cloning efficiency following FBN treatment
was also noted with BHK-21, but again the increase was noted
only early in experiments similar to results obtained with
"feeder" experiments (Table 22).
No clones were noted with FBN treatment with cell
lines that do not clone in soft agar (LT-2, WI-38, M.S.).
Antifibronetin treatment of AU-471 resulted in complete
suppression of soft agar colony formation.

No toxicity was

noted in preplate controls plated with antifibronectin and
cell attachment was noted.

Normal goat serum added in

comparable concentrations was not statistically
significantly different from control plates without NGS
(Table 23).
Antifibronectin treatment of BHK-21 resulted in

TABLE 21
ENHANCED CLONING EFFICIENCY OF A MALIGNANT
CELL LINE - AU-471 BY FIBRONECTIN
Experiment
1

Treatmentb
0
+FBN

2

Day 16
12

±

84 ± 20

91

±

4

284

±

17

3

+FBN

61

±

6

+FBN
a
b

8

-

±

0

200 ±
Day 31

41 2"

8

83 2"

5

Day 13
4

17

p

12

+FBN

.03

±

108

Day 13
0

0

-

2

Day 14
3

Colony Count (Mean± S.D.)
pa
Day 28

12 2"

1

±

9

71

.001
p

.008
p

.008

.001
p

18

264 2" 16

N.S.

Day 30

p

168

:1:

6

335

±

19

= P values compare significance to cultures with 0 FBN
= Good growth was noted by untreated and +FBN cells plated
culture plates and overlaid with agar

±

.007
p

Day 31
272

pa

.004

on the bottom of

_.
V'l
V'l

TABLE 22
ENHANCED CLONING EFFICIENCY OF AN ANCHORAGE INDEPENDENT
"NORMAL" CELL LINE - BHK-21 BY FIBRONECTIN
Experiment 1
Treatment
0

+FBN

Day 14
146

±

5

191

:!:

8

+
Colony Count (Mean- S.D.)
pa
Day 31

.004

169

±

4

215

:!:

9

pa

.01

Experiment 2
0

+FBN

Day+13
412 - 21
881

:!:

20

pa
.0001

Day+30
434 - 11
864

:!:

24

pa
.0001

a = P values compare 0 FBN with +FBN cultures

-

U1
0\

TABLE 23
SUPPRESSION OF SOFT AGAR CLONING EFFICIENCY OF AU-471
BY ANTIFIBRONECTIN

Treatmentd
0

Anti-FBNa
NGSb

Colony Count (Mean -+ S.D.)
Day 14
Day 26
7

±

2

0

Colonies too small
to score

46C

±

8

0

29C ± 4

a = Anti-FBN - antifibronectin
b
c

= NGS = normal goat serum
= No statistical significant

difference between control cultures with PBS

or NGS
d

=

All cells demonstrated good viability when incubated with PBS, Anti-FBN or
NGS and plated on the bottom of culture dishes and overlayed with soft agar

...

1.1'1

.....
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significant suppression of cl9ning efficiency at 14 days
p

= 0.0008)

and day 26 (

=

.007), but normal goat serum

also produced significant suppression (P
p

=

.008 at day 26).

=

0.009 at day 14,

There was no statistical significance

between antifibronectin treated and normal goat serum
treated.

The reason for clone suppression by normal goat

serum was not evident. (Table 24).

TABLE 24
SUPPRESSION OF SOFT AGAR CLONING EFFICIENCY
OF BHK-21 BY ANTIFIBRONECTIN

Treatmente

198 ±

0
NGsa
Anti-FBNb

a
b

Day 14
4

138 ± 19C
129

±

8C

Colony Count (Mean± S.D.)
pf
Day 26
pf

.009
.0008

215 ±

9

133 ± 23d

.008

±

.007
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15d

= NGS = normal goat serum
= Anti-FBN = antifibronectin

c = No statistical significant difference between Anti-FBN and NGS at day 14
d

= No

e

=

f

=P

statistical difference between Anti-FBN or NGS at day 26

All cells demonstrated good viability when incubated with PBS, Anti-FBN
or NGS and plated on the bottom of culture dishes and overlayed with soft
agar
values compare significance to 0 treatment control groups
~

VI
1.0
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G.

CELL SU3STRATUM AND ANCHORAGE INDEPENDENCE
AU-471 grows as heaped up or piled up cells,

indicating lack of contact inhibition and has a high
saturation density.

Cells harvested from flasks indicate

that floating cells composed 8% of the total AU-471 cells,
and were 85.2% viable.

Loosly attached cells composed 74%

of total cells and were 91.0% viable. Substratum attached
cells accounted for only 18% of the total cell population
and were 88.2% viable.
These findings were in marked contrast with LT-2 which
grows as a strict monolayer where floating cells composed
5% of the total with only 7.3% viable.

Loosely attached

cells composed only 1.28% of total cells and were all dead.
Substratum attached cells constituted 93.7% of total cells
and were 62.2% viable.
Soft agar plating of floaters, loosely attached and
substratum attached· AU-471 cells at 2 x 103 cells per plate
revealed a significant difference in cloning efficiency at
14 days of floaters compared to loosely attached (P
and substratum attached cells (P = .0001).

=

.0002)

There was no

difference between loosely attached and substratum attached
cells (Table 25).
Similar results were noted at 26 days, with 20 x 103
cells per culture significant differences were also noted

TABLE 25
SOFT AGAR CLONING EFFICIENCY OF FLOATING, LOOSELY ATTACHED
AND SUBSTRATUM ATTACHED AU-471 CELLS
Type
Cells

Number Viable
Cells x 103

Colony Count (Mean± S.D.)
p
p
Day 14
Day 26

±

2

.0002

86b±

9

.002

.0001

83b±

5

.0001

-

F.L.

2

59 ±

2

L.A.

2

5aa±

3

S.A.

2

11a±

2

F.L.

20

1400

±

50

L.A.

20

598C ± 16

.0006

2057d± 82

S.A.

20

43QC ±

.0001

1072d±

F.L.

= Floating

L.A.

=

cells

Loosely attached cells

S.A. = Substratum attached cells

2

-

a= N.S. (No
lettered
b = N.S. {No
lettered
c = N.S. (No
lettered

177

2603

± 45

5

.004
.0001

significance)between groups
"a"
significance) between groups
"b"
significance) between groups
"c"

d = Significant at P = .0002 between groups
lettered "d"

....
....

0'1
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between floaters and loosely attached cells (P
substratum attached (P
noted at 26 days.

=

=

.0006) and

.0001) and similar findings were

No differences

w~re

noted between

loosely attached and substratum attached cells at 14 days,
but a significant difference was apparent by day 20 (P

=

.0002).

·I
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H.

NUDE MICE
The ultimate test of tumorgenecity of an in vitro

cultured cell line is growth and tumor production in an
appropriate animal host like the nude mouse.

Experiments

were done to evaluate LT-2 tumorgenecity in nude mice.
Tumor nodules were noted in one of two nude mice

v.

injected s.c. with 4 x 106

LT-2 (Table 26).

was harvested after seven months observation.
animals receiving 8 x 166

v.

This nodule
One of two

LT-2 cells s.c. developed two

nodules which were harvested at three months and were 3 x 4
mm and 2.5 x 2.5 mm respectively.
inoculated with 10 x 106

v.

Three of four animals

cells s.c. were sacrificed after

four and one half months with nodules measuring 4 mm, 3mm
and 2 mm (Figure 16.).

The exact interval from injection to

first appearnace was difficult to evaluate.
receiving 10 x 106

v.

In one animal

LT-2 cells, the s.c. "bleb" produced

by injection never fully disappeared before enlargement
began.

Once a visible lesion was definitely discernable 1/2

- 1 mm, growth was very slow.

No metastasis was noted in

animals receiving s.c. injections that developed tumor
nodules.

Histologic section revealed a relatively

well-differentiated epithelial tumor (Figure 17) compared to
the original tumor (Figure 18).

Injected cell suspensions

had organized themselves into a well recognizable

TABLE 26
NUDE MICE

No. Mice

No.
Cells

Cell
Type

Route of
Injection

Date
Injected

Date
Harvested

Duration

Nodule
1/2

2

4x1o6

LT-2

S.C.

4/28/78

11/29/78

7 months

4

8x1o6

LT-2

s.c.

8/05/78

10/11/78

approx. 2 mos. 2/4*

4

10x1o6

LT-2

s.c.

7/17/78

11/29/78

approx.4-1/2
mos.

3/4

Metastasis
3

5x1o6

LT-2

I. v.

4/28/78

6/20/78
7/06/78
.

33 days
49 days

0

3

1x1o6

LT-2

I. v.

4/28/78

7/26/78
8/8/78

89 days
102 days

0
0

4

1x1o6

LT-2

I. v ..

5/12/78

11/28/78

200 days

0

2

2x1o6

AU-471

I. V.

5/02/78

6/20/78
7/06/78

49 days
65 days

0
0

*Two separate nodules noted in one mouse.

First noted at 7 weeks.
0'1
~
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Figure 16.

Nude mouse showing growth of tumor nodule.
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Figure 17. Histology of nude mouse nodule showing organization into an epithelium with differentiation reflected by
keratini toward the center of the nodule.
(Hematoxylin and
eosin.)

16 7

Figure 18. Patient M.L. biopsy of right inguinal lymph
node.
(Hematoxylin and eosin x 1 2 5. }
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epithelium.

All nude mouse nodules demonstrated central

keratinization with cells becoming flattened and hyalinized
as they progressed toward the center of the nodule
indicating cell differentiation as they progressed inward
in the tumor nodule (Figure 19).
bi-or-tri-polar mitotic plates.

Some cells demonstrated
Some mononuclear.

inflammatory cells were noted to surround some nodules
suggesting a host (nude mouse) immune reaction.
Two nude mice tumor nodules were successfully cultured
in vitro.

Cell morphology remained similar to LT-2 with

strict monolayer growth and no piling or heaping up of
cells.

No change in growth characteristics or morphology

could be noted.
Subsequent soft agar cultures of the two in vitro
cultured nude mouse nodules showed no anchorage independent
growth.

Karyotyping of these cells indicated that they were

of human origin with metacentric, submetacentric and
acrocentric chromosomes present.

The cells were aneuploid

with considerable variation in chromosomal number similar
to karyotyping of LT-2 prior to nude mouse injections
(Table 27).

Control nude mouse skin cells were also placed

in culture and revealed only telocentric chromosomes
characteristic of mouse cells.
No metastasis to liver, spleen, kidney or other
peritoneal cavity was noted in 10 mice injected
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Figure 19. Cross section and high-power magnification of
nude mouse nodule showing epithelial formation with keratinization.
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TABLE 27
LNM 7 (NUDE MOUSE LINE-7) CHROMOSOME FREQUENCY
DISTRIBUTION OF 18 CELLS

Cells:

2

2

1

1

2

1

1

Chromosomes:57----=s9----61----~62----~63----~64----~65

_____

Cells:
2
2
1
1
2
Chromosomes:67----=69----7o----=71----=73 _________________
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intravenously with 1 x 106 or 5 x 106
the mice injected with 2 x 106

v.

v.

AU-471.

LT-2 cells or in
Duration of

observation ranged from 33 days to 200 days.

CHAPTER V
DISCUSSION
Vulvar carcinomas comprise 3-4% of gynecologic malignancies (207).

These squamous cell carcinomas dlffer from

other skin cancers arising elsewhere in the body in that
they are particularly malignant with an overall five year
survival rate of only 60-70%, even with very aggressive
therapy.

Isolation of LT-2 in tissue culture afforded a

good opportunity to study in detail an uncommon malignancy.
Such studies have revealed some particularly interesting
properties.
The only absolute test of malignancy for an in vitro
cell line is its biological behavior in the autologous
host.

Because such testing is impossible, a variety of al-

ternate test systems and criteria have been developed to
evaluate the malignant potential of cultured cells.
Based on extensive study of the growth properties of
human embryonic and adult lung fibroblasts, Hayflick (208)
postulated the following criteria for malignancy in vitro:
1.

Heteroploidy

2.

Morphology (histologic 'criteria of malignancy)

3.

Indefinite growth (ability to be propagated continually in culture).
172
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Other criteria of malignancy include growth in an immunode!icient test animal (nude mouse) and/or anchorage independent growth in soft agar (209, 210, 211, 212).

These

criteria have been accepted and confirmed to some extent by
many investigators, but some apparently "normal" cells have
also been established in continual cell culture.

Although

most normal human cells in tissue culture undergo senescence
and will not proliferate past 50-70 generations, occasional
normal cells undergo an "immortality event", generally with
a change in cell growth kinetics resulting in a continuous
proliferating cell line (213, 214).

Although initially di-

ploid these cells generally convert to a heteroploid karyotype in tissue culture.

"Normal" diploid cells in culture

can also mimic the morphologic appearance of malignant
cells.

While mimicking some of the properties of malignant

cells, these immortal or established presumably non-malignant cell lines have not been found to produce clones when
cultured in soft agar, and do not produce tumors in 8-10
weeks when injected into an appropriate animal model like
the nude mouse (215).
Therefore, the definitive criteria of malignancy remain
1. the ability of the cells in question to proliferate into
progressively growing tumors in syngeneic, immunosuppressed, or immuriodeficient animals, and 2. anchorage-independent cell growth, such as in soft agar suspension.
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Cultured LT-2 cells amply satisfy Hayflick's criteria
of malignancy in vitro, with a heteroploid chromosome
complement, abnormal cytology, and continued growth in culture beyond 70 generations.

Most important, LT-2 cells sat-

isfy the criteria of Shin et al (216) for tumorigenicity in
the nude mouse, consisting of the appearance of a palpable
nodule at the site of injection within 10 weeks, and colony
formation in soft agar suspension.

Although such criteria

are the most stringent currently available, they are not
infallible.

For instance, malignant tumor cells taken di-

rectly from a cancer may not grow in a nude mouse because of
metabolic considerations.

Unfortunately, no single cellu-

lar property has been found which adequately defines the
malignant state.

The present criteria of malignancy of in

vitro cells are based on a variety of parameters which include the heterogeneous properties of cancer cells, but exclude normal cells.
Concern has been expressed regarding the use of cultured cells as models of malignancy, because of possible
selective pressures occurring in vitro with resulting alterations in antigenicity or metabolism compared to the
original tumor.

Such concerns are valid and alteration in

any given parameter may occur in vitro within the limits imposed by the genetic information of the cells.

On the other

hand, many cell lines maintained in culture for long peri-
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ods have continued to express properties of the original
tumor type.

For example, the BeWo cell line (a choriocar-

cinoma) has continued to secrete hCG despite 11 years in
tissue culture (217).

Isoenzyme phenotypes in cultured

cells nave also been found to remain stable, even in the
face of karyotype instability, treatment with mutagens, and
malignant transformation (218, 219).

In studies of kary-.

otype stability in long-term cultures, Fraccaro (220) noted
that abnormal karyotypes do not necessarily predispose to
instability, and long-term cultures may accurately reflect
the tissue of origin.

The RPM! 2650 cell line was reported

to show very little change in karyotype over a period of
one year in culture.

(221).

Other studies of cell lines have noted a numerical
drift in chromosome complement in culture (222).

Analogous

exceptions to the stability of other malignant cell properties during continual culture have also been reported
(223).

Consequently, interpretation of observations using

any cultured tumor cell line must be made in view of alterations that may result from continual cell propagation in
vitro.
However, alterations in cell properties may not be limited only to malignant cells in vitro.

Altered subclones

may also occur in vivo in any large tumor cell population
as a result of spontaneous mutations or selective pressures

176

occurring in the expanding tumor cell population.

Even a

one centimeter tumor represents nearly 30 cell doublings and
more than one billion cells, giving ample opportunity for
development of subclones.

In fact, Baumal and Scharff (224)

noted subclones of MOPC 173 myeloma cells produced by in
vivo passage, as judged by their immunoglobin secretory products.

In vivo development of subclones is also indicated

by non-CEA producing primary tumors with CEA producing metastases.

Harvey et al (225) demonstrated heterogeneity of

immunoreactive CEA extracted from various tumors, showing
differences in carbohydrate composition and molecular
weight.

No

immunoreacti~e

CE~

was found in breast carcino-

mas (an epithelial tumor), but CEA activity was found in
metastases in the liver, verifying subclonal variation of
tumors in vivo.

Similarly, a CEA producing tumor recurring

following treatment may no longer express CEA activity.
Thus, alteration in karyotype or phenotypic expression in
malignancies may occur both in vivo and in vitro.
Interestingly, after 4 years in tissue culture and
after passage through nude mice and reculiuring in vitro,
the karyotype of LT-2 still revealed a wide separation in
chromosome numbers with no modal number (variations from 57
to 73 chromosomes in 18 karyotypes).

Despite the presence

of many subclones and markedly variable chromosomal number
and continued growth and subcultivation in tissue culture,
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LT-2 was still capable of some degree of differentiation as
noted in the nude mouse tumor nodule.

A single cell suspen-

sion was injected subcutaneously on the back of nude mice,
resulting in the formation of a tumor nodule.

This nodule

was not a mass of unorganized cells or tissue, but instead
formed into a recognizable skin with cells further differentiating towards the center of the nodule forming keratin.
This remarkable cell differentiation would appear to be
ploidy-independent, since the cells injected and recovered
consisted of many subclones with variable chromosomal numbers and morphology.
Similarly, over the years of observation with close to
one thousand soft agar cultures using LT-2, no anchorage
independent growth could be demonstrated.

(Small clusters

of cells were frequently noted, but no colonies over 25
cells.)

LT-2 also continued to grow as a strict monolayer

with minimal heaping-up of cells as noted with most malignant cells grown in culture.

The stability of these cell

phenotypes despite the wide karyotypic variability suggested
that these phenotypes may also be ploidy-independent.

Al-

though there may be a variety of explanations, the work of
Jacob and Monod regarding control of gene expression would
appear to be pertinent (226).

St"udies of the induction of

the a-galactosidase (lac) gene in bacteria revealed a repressor gene product wnich controlled expression of 8-ga-
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lactosidase.

Mutations in the regulator gene resulted in

constitutive expression.

There are only about 10 soluble

repressor molecules for the lac gene in Escherichia-coli
(227).

The balance between the availability of repressors

and binding sites on the structural gene operon (operator)
is critical.

If a similar repressor control system is pre-

sent and operational in eukaryotic cells, it is not unreasonable to expect the ratio of repressor molecules to operator binding sites to be important.

Variations in chro-

mosomal number may result in disturbances of such a delicate ratio when the repressor and operator are physically
located on different chromosomes.

Repression or derepres-

sion of gene function might consequently result from variation in chromosomal number.
Cancer cells with karyotypic variations might therefore
result in variations in expression of ploidy-independent
phenotypes, while ploidy-independent phenotypes and functions would remain inviolate.

Obviously all genes have a

degree of ploidy-independence in that the total lack of a
gene results in an absence of expression.

Yet, much of the

cell metabolism and basic housekeeping functions of cells in
culture can occur despite considerable variation in karyotype and even some degree of differentiation, as clearly
demonstrated by LT-2.

These basic cell functions for all

intent and purpose, would appear to be ploidy-independent.
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on the other hand, consistent cell regulation and control
as evident in normal cells in the total organism would appear to be much more sensitive to variations in chromosomal
number.

Most embryos with abnormal karyotypes are aborted

and one has only to consider the many problems of the
Down's Syndrome child born with 3 No. 21 chromosomes, to ap·preciate the effects of even small changes in the delicate
balance of gene dose.
A definition of an in vitro ploidy-independent phenotype could be the following:

a consistent expression of a

phenotype or function despite considerable karyotypic variation in a large number of cells.

Also important in such

consideration is the stability of the karyotypic variations.

If cell chromosomal sorting at the time of mitosis

is highly variable, the potential of a whole spectrum of
cells with wide karyotypic variation and consequently
ploidy-independent phenotypes would be realized.

Ploidy-

independence arising from karyotypic variation might require
repressor and operator genes to reside on different chromosomes or at least different loci on translocated chromosomes.

Undoubtedly large tumor populations could poten-

tially express new (derepressed) genes, secondary to loss of
environmental controls (soluble regulators) or from mutation
of repressor genes on the same chromosome with selection
for such positive cells.
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The patient M.L., discussed in this report, was found
to have a serum CEA concentration of 9.8 ng/ml, despite the
epithelial origin of her vulvar tumor.

Subsequently, cul-

tured cells LT-2 derived from a lymph node metastasis of
this tumor were found to produce .877 ng CEA/106 cells/day
(above fetal calf serum CEA levels).

The presence of CEA

activity noted both in vivo and in vitro and subsequent l?SS
with passage in culture reflect the dynamic state of tumor
cells which may occur both in the test tube or in the patient.

These vagaries are the realities which must be con-

sidered by both cancer researchers and therapists.
Sensitization to CEA in s?me cancer patients has been
reported.

Gold (228) noted circulating antibodies against

CEA, and Costanza et al (229) noted CEA antibody complexes
in a patient with nephrotic syndrome and colon cancer.

The

secretion of CEA by cells in tissue culture may explain some
cases of specific lymphocyte mediated cytotoxicity or lymphoblast transformation in CEA sensitized patients.

Fetal

calf serum (FCS) should not be used in either test (LMC or
lymphoblast transformation) since sensitized patient lymphocytes could potentially respond to the CEA in FCS.
An intriguing line of investigation suggested by properties of the LT-2 line is the apparent relationship between human malignancy and cellular production of the beta
subunit of human chorionic gonadotropin (~-hCG).

McManus et
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al (230) have demonstrated,~-hCG on the cell surfaces of 25
or 28 different tumors using peroxidase-labelled antibody
staining. Active tumor cell production of B-hCG in vitro
has also been noted, not only in this study of LT-2 which
secretes about 4 ng/106 cells/day (0.1% of thefi-hCG production noted in the choriocarcinoma cell line BeWo), but
also by the cervical carcinoma cell line CaSki (231) and an
ovarian carcinoma cell line (232).
The only non-malignant source of biologically active
hCG known is trophoblastic tissue, which actively invades
the uterine endometrium during early pregnancy.

Serum con-

centration of hCG begins to decline during gestation at
about the same time that active endometrial invasion by
trophoblasts ceases (233).

(A recent report suggests low-

level hCG production by liver and colon of normal individuals, but this hCG is apparently non-functional) (234).
LT-2, a relatively well-differentiated cell line derived from a metastatic lesion also produces and secretes
the beta subunit of hCG.

Further research will be needed to

determine whether the expression of/.1-hCG by such a wide variety of tumors as noted by McManus et al is integrally involved in the cancer process or simply the random expression of a normally repressed gene. (235).
LT-2 retained its original ABH blood group type.

Many

tumors have been reported to change their blood group types
(236).
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Despite some of the malignant properties of LT-2 like
continued growth in culture, abnormal karyotype, lectin agglutination, production of fetal antigens like CEA,

-hCG

and most importantly growth in vivo in the nude mouse, LT-2
has retained some normal cell phenotypes.

LT-2 grows as a

very strict monolayer in culture and this is

ref~ected

by

the relatively low saturation density compared to AU-471 at
the same serum concentrations.

Low saturation density and

monolayer growth are frequently used criteria for contact
inhibition.

Yet, frequent cell division can be noted within

large colonies of cells despite cell contact on all sides.
Time lapse cinematography has clearly confirmed a lack of
contact inhibition of both cell division and locomotion by
LT-2.

Abercrombie has suggested that contact inhibition

can result from the devlopment of strong lateral adhesions
to adjacent cells during cell-cell collisions or the inability of the dorsal surface of one cell to provide an adequate substratum for locomotion for another cell. (237)
Studies by Middelton (238) in which cells were plated on
confluent monolayers suggest that the latter phenomenon is
more important.

Time lapse studies by Steinberg also sug-

gest avoidance of overlapping as the main mechanism for
monolayer growth (239).
monolayering by LT-2.

Both mechanisms might apply to
Our time lapse studies have demon-

strated the formation of strong lateral adhesions resulting
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from cell-cell collision, although these lateral adhesions
were not sufficient to prevent a colliding cell from moving
away from a cell colony.
noted.

Avoidance of overlapping was also

LT-2's low saturation density would therefore ap-

pear to result not from contact inhibition per se, but from
a strong tendency to monolayer growth, and may therefore
result from either the formation of strong lateral adhesions
and/or the inability to use the dorsal surface of another
cell for adhesions.

A preferential strong adhesion poten-

tial for the plastic substratum rather than another cell
might also be a possible explanation.
Holley has noted th.at the. phenotype of contact inhibition is serum dependence (240).

Cell growth continues with

an increase in saturation density when fresh serum is added
to contact inhibited monolayer cell cultures.

Holley iso-

lated a factor from serum, and Temin (241) isolated a growth
promoting factor from contact inhibited media of a cell
line that demonstrated such serum independence.

Lipkin

(242) has also reported a factor produced by contact inhibited cells that restores contact inhibition to malignant
melanocytes.

LT-2 requires growth factors found in serum

for stimulation of growth, but not for metabolism and cell
survival as demonstrated by a lack of cell division in the
absence of serum, but good cell survival.

The necessity

for an additional factor (not in serum) produced by LT-2 for

184
stimulation of cell division is suggested by the inability
to clone LT-2 in small wells in Cuprak dishes even with
conditioned media, and the requirement for as many as
500-1000 cells per well in a 96 well cluster dish to obtain
colonies and cell growth.

The presence of some types of

growth stimulation is also suggested in the soft agar
feeder experiments in which LT-2 increased anchorage independent cloning efficiency of AU-471.

WI-38 also increased

cloning efficiency of AU-471 in soft agar and is known to
produce a growth factor unin vitro (243).

Since neither

cell (LT-2 nor WI-38) clones in soft agar, this growth promoting factor would appear to stimulate cell division, but
not anchorage independent growth per se.

Conditioned media

could also transfer the growth stimulation.

Anchorage in-

dependence could not be produced by co-cultiviation of AU471 with LT-2, suggesting that these phenotypes are either
not controlled by a soluble mediator or the mediator is in
such low concentration or so labile that it is not efficient
in stimulation of anchorage independent growth by LT-2.
Spandidos and Siminovitch were able to transfer anchorage independent growth by means of metaphase chromosomes (244).
Field count experiments showed a small increase in the
number of LT-2 in soft agar cultures suggesting that a few
cells were able to divide in soft agar.

These may be cells
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already committed to cell division before plating in the
soft·agar.

Such anchorage independent growth suggests that

cell division can occur in an anchoiage independent environment even by a cell that will not normally clone without
dnshcrage, and the absence of cell division under the conditions of anchorage independence results from the control
of the initiation of cell division rather than the
tion of the division process itself.

inhibi~

Stanbridge (245) has

noted a separation of in vitro transformation phenotypes
like absence of contact inhibition and lack of density-dependent inhibition of growth, lectin agglutination, serum
independence, and anchorage independence from malignancy in
vitro using HeLa and normal fibroblast hybrids.

BeLa-fi-

broblast hybrids retained the in vitro transformation
phenotypes, but lost their in vitro malignancy potential.
LT-2 also clearly demonstrates that these phenotypes are independent, but in contrast, LT-2 grows in nude mice demonstrating its malignant potential, but retains many normal in
vitro phenotypes that are usually regarded as associated
with malignancy.
Fibronectin increased cloning efficiency in soft agar
of AU-471, but had no effect on LT-2 or WI-38.

Anti-fibro-

nectin had a marked inhibitory effect on anchorage independent growth of AU-471, but not BHK-21.

These experiments

suggest that fibronectin is necessary but not sufficient for
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anchorage independent growth.

These findings were surpris-

ing since fibronectin has been associated with restoration
of normal phenotypes and monolayer growth in transformed
cells.
Although tumor nodules could be repeatedly produced by
subcutaneous injection of LT-2, no tumors were produced following intravenous injection of either LT-2 or AU-471.

Var-

iation in tumor formation with route of injection is well
recognized (246}, and might result from differences and local microenvironmental conditions or from an active process
of cell destruction by macrophages or other cells in the
nude mouse.

Interestingly metastases are uncommon even for

massive subcutaneous tumors in the nude mouse, suggesting
some controlling mechanism.
The patient M.L.'s lack of specific tumor antigen recognition, ascertained by lymphocyte-mediated cytotoxicity,
lymphoblast

transf~rmation

and in vivo autologous tumor an-

tigen skin test response, may reflect a lack of antigenicity of her tumor cells or a specific suppression of immune
response to tumor antigens.

However, the absence of general

immune responses to both microbial recall skin test antigens
and DNCB is more consistent with a state of total immune
suppression.

Lymphocyte numbers, total T-cell, active T-

cell, and B-cell fractions, and mitogen stimulation of lymphocytes are also consistent with a total suppression of
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the patient's immune system.

A spontaneous (nonspecific)

LMC of the patient's lymphocytes versus unrelated malignant
cells significantly lower than normal lymphocytes is consistent with recent observations that spontaneous LMC is depressed in cancer patients. (247, 248).
The repeated re-evaluation of both in vivo and in vitro immuno-competency over a 15 month period of observation
clearly demonstrates the dynamic interaction of the host
with its tumor and disease process.

The presence of a posi-

tive DTH to a bacterial recall skin test antigen (dermatophytin-0) which became negative a little over a month later at the same time that the patient converted from a
negative to a positive PPD skin test demonstrates the rapid
development of anergy while retaining the ability to respond
to a primary immunization with PPD.

The response to PPD im-

munization occurred despite the fact that the patient did
not respond to a primary immunization with another antigen
- DNCB.

Likewise, the marked suppression in cytotoxicity

discussed above which increased to a statistically significant degree shortly before the patient's death also testifies to the dynamic equilibrium between energy and immune
responsiveness in the cancer patient.

It suggests caution

in interpretation of'studies of immunocompetency in cancer
patients where observations are made at only a single point
in time.

The variations in responsiveness to PPD and DNCB
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are another example of the vagaries of the immune systems in
cancer patients.
Any immune responses on the part of a tumor host to
its autochthonous tumor require either the presence of a
"foreign" or "new antigen" expressed by the tumor or a
breakdown in the patient's normal tolerance recognition
system with a resulting response to self antigens expressed
by the tumor.
tumor patients.

Both types of responses have been reported in
No immune responsiveness was noted in this

study as evaluated by in vivo skin testing with autologous
tumor extracts and in vitro by lymphocyte blast transformation in the presence of extracts of the tumor (LT-2).

The

15% specific cytotoxicity noted shortly before the patient's death suggests that a tumor antigen might be present on LT-2.

In vitro studies have demonstrated that the

tumor has retained its original blood group type with no expression of Rh antigens (normally restricted to red blood
cells and not seen on epithelial cells), but did express CEA
which is unusual for an epithelial tumor.

The expression

of fi-hCG (which is normally expressed only by trophoblastic
cells), and lectin binding (indicating changes in carbohydrate composition of the cell membrane which are generally
noted in tumor cells but not in normal cells), and reactivity with normal rabbit serum also suggest the presence of a
"new antigen".

All of these findings indicate an "abnormal
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or unusual" antigen expressed on LT-2 which could have been
responsible for the cytotoxicity noted.
Lev in, et al, ( 249) have reported responses of household contacts of cancer patients to allogenic tumors using
a cytotoxicity assay.

No such antigen exposure of the pa-

tient's sister could be demonstrated using the sister's lymphocytes in a blast transformation assay to LT-2 tumor extracts in this study.
The cytotoxicity assay used in this study involved the
use of an in vitro cultured autologous tumor.

Most studies

in the past have involved the use of allogeneic tumor cells
or on occasion, fresh tumor tissue.

The rationale for the

use of allogeneic tumor is based upon the concept of a
shared tumor antigen between histologically similar tumor
types.

Unfortunately, the same studies which are used for

supporting the concept that histologically similar tumors
share the same common tumor antigen are used as proof of
cytotoxicity to tumor cells.

Proof of a shared "tumor an-

tigen" in most histologically similar tumors in humans is
poor at best.

Dodson and Menon (250) have recently re-

viewed the subject of "tumor antigens", and their possible
mechanism of production and have emphasized the vagaries of
antigen expression between different tumors and even between cells of the same tumor and note that except for viral antigens, most "tumor antigens" are a reflection of the
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karyotype and metabolic vagaries of the tumor cell.

Al-

though such "tumor antigens" have been amply demonstrated in
viral induced tumors in experimental animals, and have been
suggested in humans in Burkitt's Lymphoma and possible malignant melanoma, their presence in most human tumors is
questionable.
The great bulk of tumor cytotoxicity studies are also
questionable because of the recent observation by Zinkernagel and Daugherty {251) regarding the major histocompatibility restrictions between the cytotoxic effector cell
and the target cell.

In order for cytotoxic T-cells to kill

virus infected cells expressing new (viral) antigens, the
lymphocyte and infected cell must share the same histocompatibility antigens.

This cytotoxicity system - killing

self cells expressing new antigens (viral in the case of infected cells) would appear to be a similar system to that
proposed for immune.surveillance in which cancerous self
cells expressing new antigens are destroyed.

Allogeneic

cells with viral antigens are not killed in this system.
Undoubtedly, the body contains a mechanism for rejecting
foreign tissue as demonstrated by graft rejection, but it
would not appear to be the same cytotoxicity system that
checks self cells for new antigens since allogeneic cells
are not affected in the system illustrated by Zinkernagel
and.Daugherty.

A lack of a tumor antigen in histologically
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similar tumors, and a lack of histocompatability between
target and effected cells in allogeneic cytotoxicity systems results in serious questions regarding the great majority of such tumor studies currently in the literature.
The use of fresh tumor avoids the problem noted above,
and may give some significant data, but it also raises other
questions.

The general method of processing tumors in-

volves mincing the tissue into small pieces and sometimes
treatment with enzymes to disperse the cells.

Such a pro-

cess results in the presence of many fibroblasts.

As a con-

sequence, it is difficult to compare values since a low cytotoxicity score may simply reflect a high percentage of
fibroblasts rather than a lack of cytotoxicity between lymphocyte and target cells.

Enzymes may modify or destroy

surface antigens, also raising questions regarding cytotoxicity data when tissue is processed in this manner.
Undoubtedly, the use of culture cells can also be
criticized on the basis that cells may change their phenotype, karyotype or other properties while in tissue culture.
Although such changes may occur in vitro, they may also occur in the tumor mass in vivo.
These questions of techniques are not simply academic.
Cytotoxicity studies have suggested that tumors possess new
"tumor antigens", and that the immune system is capable of
destroying tumor cells.

Yet the data are in conflict with
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common clinical observations -that tumor progression is common and immunological tumor regression is exceptionally
rare.

Enthusiasts of immune surveillance suggest that tu-

mors are common, and that it is the immune system that
kills most of these tumors very early, before they are
clinically evident.

Unfortunately, the theory has been

difficult to test clinically, and cytotoxicity data which
has been used to support the concept of immune surveillance
is questionable for the reasons discussed above.

Perhaps

there is an immune surveillance system with cytotoxic lymphocytes despite the problems with experimental design of
many cytotoxicity studies previously published.

Additional

research will be needed to answer this question, but should
be done with autologous tumors and lymphoctyes if relevant
data are to be obtained.
A particularly interesting finding in this study is the
dissociation of the phenotypes of in vivo malignancy and
anchorage independent growth by LT-2.

Only a few tumors

have been reported that fulfill the stringent criteria of
tumor formation in the nude mouse, but that will not clone
in soft agar.

The studies and experiments presented here

raise serious questions regarding the use of anchorage independent growth as the ultimate in vitro criterion of malignancy.
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LT-2 is capable of cell division in an anchorage independent environment as revealed by field count experiments
in this work, but colony formation does not occur.

The con-

trol of soft agar cloning would therefore appear to involve
initiation of cell division rather than a limitation of the
capacity for mitosis.

This is not surprising since even

cells growing in monolayers "round-up" during cell division
and are already "rounded" in shape when plated in soft agar.
Fibronectin increases anchorage independent growth of
malignant cell lines, but does not initiate soft agar
growth by LT-2.

Anti-fibronectin decreases anchorage inde-

pendent growth.

Therefore, fibronectin is necessary but

not sufficient for anchorage independent growth.

No solu-

ble stimulants released by an anchorage independent cell
line could be demonstrated, but LT-2 was capable of both
stimulation and suppression of colony formation by an anchorage independent cell line depending on dose and time in
culture.

These effects were less apparent when LT-2 was

treated with mitomycin C, suggesting that limitation of cell
division was an important factor in both processes.
Single cell suspensions of LT-2, injected into nude

.

mice, were capable of aggregating and forming an easily re-

.

cognizable skin with differentiation as reflected by keratin formation.

These findings suggest that LT-2 retains re-

ceptors for cell aggregation and the capacity for differen-
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tiation despite its malignant nature and markedly variable
and aneuploid karyotype.

Cells re-cultured in vitro from

such nude mice also demonstrate markedly variable aneuploid
karyotype indicating that some capabilities of LT-2 to organize into an epithelium and differentiate and form keratin
are ploidy independent.

Soft agar cultures of such cells

again demonstrated a lack of anchorage independent growth
confirming the separation of the phenotypes of anchorage independence and nude mouse growth even in cells passed
through nude mice.
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